Document:

Exhibit 10.6

 

REGISTRATION AND STOCKHOLDER RIGHTS AGREEMENT

 

THIS REGISTRATION AND STOCKHOLDER RIGHTS AGREEMENT
(this “Agreement”), dated as of [•], 2021, is made and entered into by and among Intelligent Medicine Acquisition
Corp., a Delaware corporation (the “Company”), Intelligent Medicine Sponsor LLC, a Delaware limited liability
company (the “Sponsor”), and the undersigned parties listed under Holder on the signature page hereto (each
such party, together with the Sponsor, and any person or entity who hereafter becomes a party to this Agreement pursuant to Section 6.2
of this Agreement, a “Holder” and collectively the “Holders”).

 

RECITALS

 

WHEREAS,
the Company and the Sponsor have entered into that certain Securities Subscription Agreement, dated as of March 8, 2021, pursuant
to which the Sponsor purchased an aggregate of 5,750,000 shares (the “Founder Shares”) of the Company’s
Class B common stock, par value $0.0001 per share;

 

WHEREAS,
the Sponsor subsequently transferred an aggregate of   275,000 Founder Shares to the other Holders;

 

WHEREAS, the Sponsor subsequently forfeited 1,437,500
for no consideration;

 

WHEREAS,
up to an aggregate of 562,500 Founder Shares are subject to forfeiture by the Sponsor if the over-allotment option in connection with
the Company’s initial public offering is not exercised in full;

 

WHEREAS,
the Founder Shares are convertible into shares of the Company’s Class A common stock, par value $0.0001 per share (the “Common
Stock”), at the time of the initial Business Combination (as defined below) on a one-for-one basis, subject to adjustment,
on the terms and conditions provided in the Company’s amended and restated certificate of incorporation, as may be amended from
time to time;

 

WHEREAS,
on [•], 2021, the Company and the Sponsor and Cantor Fitzgerald & Co. ("Cantor") entered into those certain
Warrant Purchase Agreements, pursuant to which the Sponsor and Cantor agreed to purchase 8,000,000 warrants (or up to 8,900,000
warrants if the over-allotment option in connection with the Company’s initial public offering is exercised in full) (together
with all other warrants issued by the Company to the Sponsor on substantially the same terms, the “Private Placement
Warrants”), in a private placement transaction occurring simultaneously with the closing of the Company’s
initial public offering, each Private Placement Warrant entitling the holder to purchase one share of Common Stock at an exercise
price of $11.50 per share; and

 

WHEREAS,
the Company and the Holders desire to enter into this Agreement, pursuant to which the Company shall grant the Holders certain registration
rights with respect to certain securities of the Company, as set forth in this Agreement.

 

NOW,
THEREFORE, in consideration of the mutual representations, covenants and agreements contained herein, and certain other good and
valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto, intending to be legally bound,
hereby agree as follows:

 

ARTICLE I

DEFINITIONS

 

1.1 Definitions. The terms defined in this
Article I shall, for all purposes of this Agreement, have the respective meanings set forth below:

 

“Adverse Disclosure”
shall mean any public disclosure of material non-public information, which disclosure, in the good faith judgment of the Chief Executive
Officer or any principal financial officer of the Company, after consultation with counsel to the Company, (i) would be required
to be made in any Registration Statement or Prospectus in order for the applicable Registration Statement or Prospectus not to contain
any untrue statement of a material fact or omit to state a material fact necessary to make the statements contained therein (in the case
of any prospectus and any preliminary prospectus, in the light of the circumstances under which they were made) not misleading, (ii) would
not be required to be made at such time if the Registration Statement were not being filed, and (iii) the Company has a bona fide
business purpose for not making such information public.

 

     

     

    

 

“Agreement” shall have
the meaning given in the Preamble.

 

“Board” shall mean the
Board of Directors of the Company.

 

“Block Trade” shall have
the meaning set forth in Section 2.5.

 

“Business Combination”
shall mean any merger, capital stock exchange, asset acquisition, stock purchase, reorganization or other similar business combination
with one or more businesses, involving the Company.

 

“Commission” shall mean
the U.S. Securities and Exchange Commission.

 

“Common Stock” shall
have the meaning given in the Recitals hereto.

 

“Company” shall have
the meaning given in the Preamble.

 

“Demand Registration”
shall have the meaning given in subsection 2.1.1.

 

“Demanding Holder” shall
have the meaning given in subsection 2.1.1.

 

“Exchange Act” shall
mean the Securities Exchange Act of 1934, as amended.

 

“Form S-1” shall
have the meaning given in subsection 2.1.1.

 

“Form S-3” shall
have the meaning given in subsection 2.3.

 

“Founder Shares” shall
have the meaning given in the Recitals hereto and shall be deemed to include the shares of Common Stock issuable upon conversion thereof.

 

“Founder Shares Lock-Up Period”
shall mean, with respect to the Founder Shares, the period ending on the earlier of (A) one year after the completion of the Company’s
initial Business Combination or (B) subsequent to the Business Combination, (x) if the last reported sale price of the Common
Stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like)
for any 20 trading days within any 30-trading day period commencing at least 150 days after the Company’s initial Business Combination
or (y) the date on which the Company completes a liquidation, merger, capital stock exchange, reorganization or other similar transaction
that results in all of the Company’s stockholders having the right to exchange their shares of Common Stock for cash, securities
or other property.

 

“Holders” shall have
the meaning given in the Preamble.

 

“Insider Letter” shall
mean that certain letter agreement, dated as of the date hereof, by and among the Company, its initial stockholders, directors and officers.

 

“Maximum Number of Securities”
shall have the meaning given in subsection 2.1.4.

 

“Misstatement” shall
mean an untrue statement of a material fact or an omission to state a material fact required to be stated in a Registration Statement
or Prospectus, or necessary to make the statements in a Registration Statement not misleading or, in the case of a Prospectus, not misleading
in the light of the circumstances under which they were made.

 

“Nominee” shall have
the meaning given in subsection 5.1.1.

 

“Permitted
Transferees” shall mean any person or entity to whom a Holder of Registrable Securities is permitted to transfer such
Registrable Securities prior to the expiration of the Founder Shares Lock-Up Period or Private Placement Lock-Up Period, as the case
may be, under the Insider Letter , the Private Placement Warrants Purchase Agreements and any other applicable agreement between
such Holder and the Company, and to any transferee thereafter.

 

     

     

    

 

“Piggyback Registration”
shall have the meaning given in subsection 2.2.1.

 

“Private Placement Lock-Up Period”
shall mean, with respect to Private Placement Warrants that are held by the initial purchasers of such Private Placement Warrants or their
Permitted Transferees, and any of the shares of Common Stock issued or issuable upon the exercise or conversion of the Private Placement
Warrants and that are held by the initial purchasers of the Private Placement Warrants or their Permitted Transferees, the period ending
30 days after the completion of the Company’s initial Business Combination.

 

“Private Placement Warrants”
shall have the meaning given in the Recitals hereto.

 

“Pro Rata” shall have
the meaning given in subsection 2.1.4.

 

“Prospectus” shall mean
the prospectus included in any Registration Statement, as supplemented by any and all prospectus supplements and as amended by any and
all post-effective amendments and including all material incorporated by reference in such prospectus.

 

“Registrable Security”
shall mean (a) the shares of Common Stock issued or issuable upon the conversion of any Founder Shares, (b) the Private Placement
Warrants (including any shares of the Common Stock issued or issuable upon the exercise of any such Private Placement Warrants), (c) any
outstanding shares of Common Stock or any other equity security (including the shares of Common Stock issued or issuable upon the exercise
of any other equity security) of the Company held by a Holder as of the date of this Agreement or purchased in the IPO or at any time
thereafter, (d) any equity securities (including the shares of Common Stock issued or issuable upon the exercise of any such equity
security) of the Company issuable upon conversion of any working capital loans in an amount up to $2,000,000 made to the Company by a
Holder, and (e) any other equity security of the Company issued or issuable with respect to any such shares of Common Stock by way
of a stock dividend or stock split or in connection with a combination of shares, recapitalization, merger, consolidation or reorganization;
provided, however, that, as to any particular Registrable Security, such securities shall cease to be Registrable Securities
when: (A) a Registration Statement with respect to the sale of such securities shall have become effective under the Securities Act
and such securities shall have been sold, transferred, disposed of or exchanged in accordance with such Registration Statement; (B) such
securities shall have been otherwise transferred, new certificates for such securities not bearing a legend restricting further transfer
shall have been delivered by the Company and subsequent public distribution of such securities shall not require registration under the
Securities Act; (C) such securities shall have ceased to be outstanding; (D) such securities may be sold without registration
pursuant to Rule 144 promulgated under the Securities Act (or any successor rule promulgated thereafter by the Commission) (but
with no volume or other restrictions or limitations); or (E) such securities have been sold to, or through, a broker, dealer or underwriter
in a public distribution or other public securities transaction.

 

“Registration” shall
mean a registration effected by preparing and filing a registration statement or similar document in compliance with the requirements
of the Securities Act, and the applicable rules and regulations promulgated thereunder, and such registration statement becoming
effective.

 

“Registration Expenses”
shall mean the out-of-pocket expenses of a Registration, including, without limitation, the following:

 

(A) all registration and filing fees (including
fees with respect to filings required to be made with the Financial Industry Regulatory Authority, Inc.) and any securities exchange
on which the Common Stock is then listed;

 

(B) fees and expenses of compliance with securities
or blue sky laws (including reasonable fees and disbursements of counsel for the Underwriters in connection with blue sky qualifications
of Registrable Securities);

 

(C) printing, messenger, telephone and delivery
expenses;

 

(D) reasonable fees and disbursements of counsel
for the Company;

 

     

     

    

 

(E) reasonable fees and disbursements of all
independent registered public accountants of the Company incurred specifically in connection with such Registration; and

 

(F) reasonable fees and expenses of one (1) legal
counsel selected by the Demanding Holder initiating a Demand Registration to be registered for offer and sale in the applicable Registration.

 

“Registration Statement”
shall mean any registration statement that covers the Registrable Securities pursuant to the provisions of this Agreement, including the
Prospectus included in such registration statement, amendments (including post-effective amendments) and supplements to such registration
statement, and all exhibits to and all material incorporated by reference in such registration statement.

 

“Requesting Holder” shall
have the meaning given in subsection 2.1.1.

 

“Securities Act” shall
mean the Securities Act of 1933, as amended.

 

“Sponsor” shall have
the meaning given in the Preamble.

 

“Sponsor Director” means
an individual elected to the Board that has been nominated pursuant to Section 5.1.

 

“Underwriter” shall mean
a securities dealer who purchases any Registrable Securities as principal in an Underwritten Offering or Block Trade and not as part of
such dealer’s market-making activities.

 

“Underwritten Registration”
or “Underwritten Offering” shall mean a Registration in which securities of the Company are sold to an Underwriter
in a firm commitment underwriting for distribution to the public.

 

ARTICLE II

REGISTRATIONS

 

2.1 Demand Registration.

 

2.1.1 Request for Registration. Subject
to the provisions of subsection 2.1.4 and Section 2.4 hereof, at any time and from time to time on or after the
date the Company consummates the Business Combination, (i) any Holder that together with its affiliates owns at least 20% in
interest of the then-outstanding number of Registrable Securities, or (ii) Cantor or its permitted designees (the
 “Demanding Holder”) may make a written demand for Registration of all or part of its Registrable
Securities, which written demand shall describe the amount and type of securities to be included in such Registration and the
intended method(s) of distribution thereof (such written demand a “Demand Registration”). The Company
shall, within ten (10) days of the Company’s receipt of the Demand Registration, notify, in writing, all other Holders of
Registrable Securities of such demand, and each Holder of Registrable Securities who thereafter wishes to include all or a portion
of such Holder’s Registrable Securities in a Registration pursuant to a Demand Registration (each such Holder that includes
all or a portion of such Holder’s Registrable Securities in such Registration, a “Requesting
Holder”) shall so notify the Company, in writing, within five (5) days after the receipt by the Holder of the
notice from the Company. Upon receipt by the Company of any such written notification from a Requesting Holder(s) to the
Company, such Requesting Holder(s) shall be entitled to have their Registrable Securities included in a Registration pursuant
to a Demand Registration and the Company shall effect, as soon thereafter as practicable, but not more than forty five (45) days
immediately after the Company’s receipt of the Demand Registration, the Registration of all Registrable Securities requested
by the Demanding Holder and Requesting Holders pursuant to such Demand Registration. Under no circumstances shall the Company be
obligated to effect more than three (3) Registrations per eligible Holder pursuant to a Demand Registration under this subsection
2.1.1; provided, however, that a Registration shall not be counted for such purposes unless a Form S-1 or any
similar long-form registration statement that may be available at such time (“Form S-1”) has become
effective and all of the Registrable Securities requested by the Requesting Holders to be registered on behalf of the Requesting
Holders in such Form S-1 Registration have been sold, in accordance with Section 3.1 of this Agreement.

 

     

     

    

 

2.1.2 Effective Registration. Notwithstanding
the provisions of subsection 2.1.1 above or any other part of this Agreement, a Registration pursuant to a Demand Registration
shall not count as a Registration unless and until (i) the Registration Statement filed with the Commission with respect to a Registration
pursuant to a Demand Registration has been declared effective by the Commission and (ii) the Company has complied with all of its
obligations under this Agreement with respect thereto; provided, further, that if, after such Registration Statement has
been declared effective, an offering of Registrable Securities in a Registration pursuant to a Demand Registration is subsequently interfered
with by any stop order or injunction of the Commission, federal or state court or any other governmental agency the Registration Statement
with respect to such Registration shall be deemed not to have been declared effective, unless and until, (i) such stop order or injunction
is removed, rescinded or otherwise terminated and (ii) the Demanding Holder initiating such Demand Registration thereafter affirmatively
elects within five (5) days to continue with such Registration and accordingly notifies the Company in writing of such election within
such five (5)-day period; provided, further, that the Company shall not be obligated or required to file another Registration
Statement until the Registration Statement that has been previously filed with respect to a Registration pursuant to a Demand Registration
becomes effective or is subsequently terminated.

 

2.1.3 Underwritten Offering. Subject to the
provisions of subsection 2.1.4 and Section 2.4 hereof, if the Demanding Holder so advises the Company as part of its
Demand Registration that the offering of the Registrable Securities pursuant to such Demand Registration shall be in the form of an Underwritten
Offering, then the right of such Demanding Holder or Requesting Holder (if any) to include its Registrable Securities in such Registration
shall be conditioned upon such Holder’s participation in such Underwritten Offering and the inclusion of such Holder’s Registrable
Securities in such Underwritten Offering to the extent provided herein. All such Holders proposing to distribute their Registrable Securities
through an Underwritten Offering under this subsection 2.1.3 shall enter into an underwriting agreement in customary form with
the Underwriter(s) selected for such Underwritten Offering by the Demanding Holder initiating the Demand Registration.

 

2.1.4 Reduction of Underwritten Offering.
If the managing Underwriter or Underwriters in an Underwritten Registration pursuant to a Demand Registration, in good faith, advises
the Company, the Demanding Holder and the Requesting Holders (if any) in writing that the dollar amount or number of Registrable Securities
that the Demanding Holder and the Requesting Holders (if any) desire to sell, taken together with all other Common Stock or other equity
securities that the Company desires to sell and the Common Stock, if any, as to which a Registration has been requested pursuant to separate
written contractual piggy-back registration rights held by any other stockholders who desire to sell, exceeds the maximum dollar amount
or maximum number of equity securities that can be sold in the Underwritten Offering without adversely affecting the proposed offering
price, the timing, the distribution method, or the probability of success of such offering (such maximum dollar amount or maximum number
of such securities, as applicable, the “Maximum Number of Securities”), then the Company shall include in such
Underwritten Offering, as follows: (i) first, the Registrable Securities of the Demanding Holder and the Requesting Holders (if any)
(pro rata based on the respective number of Registrable Securities that each Demanding Holder and Requesting Holder (if any) has requested
be included in such Underwritten Registration and the aggregate number of Registrable Securities that the Demanding Holder and Requesting
Holders have requested be included in such Underwritten Registration (such proportion is referred to herein as “Pro Rata”))
that can be sold without exceeding the Maximum Number of Securities; (ii) second, to the extent that the Maximum Number of Securities
has not been reached under the foregoing clause (i), the Common Stock or other equity securities that the Company desires to sell, which
can be sold without exceeding the Maximum Number of Securities; and (iii) third, to the extent that the Maximum Number of Securities
has not been reached under the foregoing clauses (i) and (ii), the Common Stock or other equity securities of other persons or entities
that the Company is obligated to register in a Registration pursuant to separate written contractual arrangements with such persons and
that can be sold without exceeding the Maximum Number of Securities.

 

2.1.5 Demand Registration Withdrawal. The
Demanding Holder initiating a Demand Registration or a majority-in-interest of the Requesting Holders (if any), pursuant to a Registration
under subsection 2.1.1 shall have the right to withdraw from a Registration pursuant to such Demand Registration for any or no
reason whatsoever upon written notification to the Company and the Underwriter or Underwriters (if any) of their intention to withdraw
from such Registration prior to the effectiveness of the Registration Statement filed with the Commission with respect to the Registration
of their Registrable Securities pursuant to such Demand Registration. Notwithstanding anything to the contrary in this Agreement, the
Company shall be responsible for the Registration Expenses incurred in connection with a Registration pursuant to a Demand Registration
prior to its withdrawal under this subsection 2.1.5.

 

     

     

    

 

2.2 Piggyback Registration.

 

2.2.1 Piggyback Rights. If, at any time on
or after the date the Company consummates a Business Combination, the Company proposes to file a Registration Statement under the Securities
Act with respect to an offering of equity securities, or securities or other obligations exercisable or exchangeable for, or convertible
into equity securities, for its own account or for the account of stockholders of the Company (or by the Company and by the stockholders
of the Company including, without limitation, pursuant to Section 2.1 hereof), other than a Registration Statement (i) filed
in connection with any employee stock option or other benefit plan, (ii) for an exchange offer or offering of securities solely to
the Company’s existing stockholders, (iii) for an offering of debt that is convertible into equity securities of the Company,
(iv) for a dividend reinvestment plan or (v) a Block Trade, then the Company shall give written notice of such proposed filing
to all of the Holders of Registrable Securities as soon as practicable but not less than ten (10) days before the anticipated filing
date of such Registration Statement, which notice shall (A) describe the amount and type of securities to be included in such offering,
the intended method(s) of distribution, and the name of the proposed managing Underwriter or Underwriters, if any, in such offering,
and (B) offer to all of the Holders of Registrable Securities the opportunity to register the sale of such number of Registrable
Securities as such Holders may request in writing within five (5) days after receipt of such written notice (such Registration, a
 “Piggyback Registration”). The Company shall, in good faith, cause such Registrable Securities to be included
in such Piggyback Registration and shall use its best efforts to cause the managing Underwriter or Underwriters of a proposed Underwritten
Offering to permit the Registrable Securities requested by the Holders pursuant to this subsection 2.2.1 to be included in a Piggyback
Registration on the same terms and conditions as any similar securities of the Company included in such Registration and to permit the
sale or other disposition of such Registrable Securities in accordance with the intended method(s) of distribution thereof. All such
Holders proposing to distribute their Registrable Securities through an Underwritten Offering under this subsection 2.2.1 shall
enter into an underwriting agreement in customary form with the Underwriter(s) selected for such Underwritten Offering by the Company.

 

2.2.2 Reduction of Piggyback Registration.
If the managing Underwriter or Underwriters in an Underwritten Registration that is to be a Piggyback Registration, in good faith, advises
the Company and the Holders of Registrable Securities participating in the Piggyback Registration in writing that the dollar amount or
number of the shares of Common Stock that the Company desires to sell, taken together with (i) the Common Stock, if any, as to which
Registration has been demanded pursuant to separate written contractual arrangements with persons or entities other than the Holders of
Registrable Securities hereunder, (ii) the Registrable Securities as to which registration has been requested pursuant to Section 2.2
hereof, and (iii) the Common Stock, if any, as to which Registration has been requested pursuant to separate written contractual
piggy-back registration rights of other stockholders of the Company, exceeds the Maximum Number of Securities, then:

 

(a) If the Registration is undertaken for
the Company’s account, the Company shall include in any such Registration (A) first, the Common Stock or other equity securities
that the Company desires to sell, which can be sold without exceeding the Maximum Number of Securities; (B) second, to the extent
that the Maximum Number of Securities has not been reached under the foregoing clause (A), the Registrable Securities of Holders exercising
their rights to register their Registrable Securities pursuant to subsection 2.2.1 hereof, Pro Rata, which can be sold without
exceeding the Maximum Number of Securities; and (C) third, to the extent that the Maximum Number of Securities has not been reached
under the foregoing clauses (A) and (B), the Common Stock, if any, as to which Registration has been requested pursuant to written
contractual piggy-back registration rights of other stockholders of the Company, which can be sold without exceeding the Maximum Number
of Securities;

 

(b) If the Registration is pursuant to a request
by persons or entities other than the Holders of Registrable Securities, then the Company shall include in any such Registration (A) first,
the Common Stock or other equity securities, if any, of such requesting persons or entities, other than the Holders of Registrable Securities,
which can be sold without exceeding the Maximum Number of Securities; (B) second, to the extent that the Maximum Number of Securities
has not been reached under the foregoing clause (A), the Registrable Securities of Holders exercising their rights to register their Registrable
Securities pursuant to subsection 2.2.1, Pro Rata, which can be sold without exceeding the Maximum Number of Securities; (C) third,
to the extent that the Maximum Number of Securities has not been reached under the foregoing clauses (A) and (B), the Common Stock
or other equity securities that the Company desires to sell, which can be sold without exceeding the Maximum Number of Securities; and
(D) fourth, to the extent that the Maximum Number of Securities has not been reached under the foregoing clauses (A), (B) and
(C), the Common Stock or other equity securities for the account of other persons or entities that the Company is obligated to register
pursuant to separate written contractual arrangements with such persons or entities, which can be sold without exceeding the Maximum Number
of Securities.

 

     

     

    

 

2.2.3 Piggyback Registration Withdrawal. Any
Holder of Registrable Securities shall have the right to withdraw from a Piggyback Registration for any or no reason whatsoever upon written
notification to the Company and the Underwriter or Underwriters (if any) of his, her or its intention to withdraw from such Piggyback
Registration prior to the effectiveness of the Registration Statement filed with the Commission with respect to such Piggyback Registration.
The Company (whether on its own good faith determination or as the result of a request for withdrawal by persons pursuant to separate
written contractual obligations) may withdraw a Registration Statement filed with the Commission in connection with a Piggyback Registration
at any time prior to the effectiveness of such Registration Statement. Notwithstanding anything to the contrary in this Agreement, the
Company shall be responsible for the Registration Expenses incurred in connection with the Piggyback Registration prior to its withdrawal
under this subsection 2.2.3.

 

2.2.4 Unlimited Piggyback Registration Rights.
For purposes of clarity, any Registration effected pursuant to Section 2.2 hereof shall not be counted as a Registration pursuant
to a Demand Registration effected under Section 2.1 hereof.

 

2.3 Registrations on Form S-3. The
Holders of Registrable Securities may at any time, and from time to time, request in writing that the Company, pursuant to Rule 415
under the Securities Act (or any successor rule promulgated thereafter by the Commission), register the resale of any or all of their
Registrable Securities on Form S-3 or any similar short form registration statement that may be available at such time (“Form S-3”);
provided, however, that the Company shall not be obligated to effect such request through an Underwritten Offering. Within five (5) days
of the Company’s receipt of a written request from a Holder or Holders of Registrable Securities for a Registration on Form S-3,
the Company shall promptly give written notice of the proposed Registration on Form S-3 to all other Holders of Registrable Securities,
and each Holder of Registrable Securities who thereafter wishes to include all or a portion of such Holder’s Registrable Securities
in such Registration on Form S-3 shall so notify the Company, in writing, within ten (10) days after the receipt by the Holder
of the notice from the Company. As soon as practicable thereafter, but not more than twelve (12) days after the Company’s initial
receipt of such written request for a Registration on Form S-3, the Company shall register all or such portion of such Holder’s
Registrable Securities as are specified in such written request, together with all or such portion of Registrable Securities of any other
Holder or Holders joining in such request as are specified in the written notification given by such Holder or Holders; provided, however,
that the Company shall not be obligated to effect any such Registration pursuant to this Section 2.3 if (i) a Form S-3
is not available for such offering; or (ii) the Holders of Registrable Securities, together with the Holders of any other equity
securities of the Company entitled to inclusion in such Registration, propose to sell the Registrable Securities and such other equity
securities (if any) at any aggregate price to the public of less than $10,000,000.

 

2.4 Restrictions on Registration Rights.
If (A) during the period starting with the date sixty (60) days prior to the Company’s good faith estimate of the date of the
filing of, and ending on a date one hundred and twenty (120) days after the effective date of, a Company initiated Registration and provided
that the Company has delivered written notice to the Holders prior to receipt of a Demand Registration pursuant to subsection 2.1.1
and it continues to actively employ, in good faith, all reasonable efforts to cause the applicable Registration Statement to become effective;
(B) the Holders have requested an Underwritten Registration and the Company and the Holders are unable to obtain the commitment of
underwriters to firmly underwrite the offer; or (C) in the good faith judgment of the Board such Registration would be seriously
detrimental to the Company and the Board concludes as a result that it is essential to defer the filing of such Registration Statement
at such time, then in each case the Company shall furnish to such Holders a certificate signed by the Chairman of the Board stating that
in the good faith judgment of the Board it would be seriously detrimental to the Company for such Registration Statement to be filed in
the near future and that it is therefore essential to defer the filing of such Registration Statement. In such event, the Company shall
have the right to defer such filing for a period of not more than thirty (30) days; provided, however, that the Company shall not defer
its obligation in this manner more than once in any 12-month period. Notwithstanding anything to the contrary contained in this Agreement,
no Registration shall be effected or permitted and no Registration Statement shall become effective, with respect to any Registrable Securities
held by any Holder, until after the expiration of the Founder Shares Lock-Up Period or the Private Placement Lock-Up Period, as the case
may be.

 

     

     

    

 

2.5 Block Trades.

 

2.5.1 Notwithstanding any other provision of this
Article II, but subject to Section 3.4, at any time and from time to time when an effective Form S-3 is on file with the
Commission, if a Demanding Holder wishes to engage in an underwritten registered offering not involving a “roadshow,” an offer
commonly known as a “block trade” (a “Block Trade”), with a total offering price reasonably expected
to exceed, in the aggregate, either (x) $10 million or (y) all remaining Registrable Securities held by the Demanding Holder,
then such Demanding Holder only needs to notify the Company of the Block Trade at least five (5) business days prior to the day such
offering is to commence and the Company shall as expeditiously as possible use its commercially reasonable efforts to facilitate such
Block Trade; provided that the Demanding Holders representing a majority of the Registrable Securities wishing to engage in the Block
Trade shall use commercially reasonable efforts to work with the Company and any Underwriters prior to making such request in order to
facilitate preparation of the registration statement, prospectus and other offering documentation related to the Block Trade.

 

2.5.2 Prior to the filing of the applicable “red
herring” prospectus or prospectus supplement used in connection with a Block Trade, any Demanding Holder initiating such Block Trade
shall have the right to submit a written notification to the Company and the Underwriter or Underwriters (if any) of their intention to
withdraw from such Block Trade. Notwithstanding anything to the contrary in this Agreement, the Company shall be responsible for the Registration
Expenses incurred in connection with a block trade prior to its withdrawal under this subsection 2.5.2.

 

2.5.3 Notwithstanding anything to the contrary in
this Agreement, Section 2.2 shall not apply to a Block Trade initiated by a Demanding Holder pursuant to this Agreement.

 

2.5.4 The Demanding Holder in a Block Trade shall
have the right to select the Underwriters for such Block Trade (which shall consist of one or more reputable nationally recognized investment
banks).

 

ARTICLE III

COMPANY PROCEDURES

 

3.1 General Procedures. If at any time on
or after the date the Company consummates a Business Combination the Company is required to effect the Registration of Registrable Securities,
the Company shall use its best efforts to effect such Registration to permit the sale of such Registrable Securities in accordance with
the intended plan of distribution thereof, and pursuant thereto the Company shall, as expeditiously as possible:

 

3.1.1 prepare and file with the Commission as soon
as practicable a Registration Statement with respect to such Registrable Securities and use its reasonable best efforts to cause such
Registration Statement to become effective and remain effective until all Registrable Securities covered by such Registration Statement
have been sold;

 

3.1.2 prepare and file with the Commission such amendments
and post-effective amendments to the Registration Statement, and such supplements to the Prospectus, as may be reasonably requested by
the Holders or any Underwriter of Registrable Securities or as may be required by the rules, regulations or instructions applicable to
the registration form used by the Company or by the Securities Act or rules and regulations thereunder to keep the Registration Statement
effective until all Registrable Securities covered by such Registration Statement are sold in accordance with the intended plan of distribution
set forth in such Registration Statement or supplement to the Prospectus;

 

     

     

    

 

3.1.3 prior to filing a Registration Statement or
Prospectus, or any amendment or supplement thereto, furnish without charge to the Underwriters, if any, and the Holders of Registrable
Securities included in such Registration, and such Holders’ legal counsel, copies of such Registration Statement as proposed to
be filed, each amendment and supplement to such Registration Statement (in each case including all exhibits thereto and documents incorporated
by reference therein), the Prospectus included in such Registration Statement (including each preliminary Prospectus), and such other
documents as the Underwriters and the Holders of Registrable Securities included in such Registration or the legal counsel for any such
Holders may request in order to facilitate the disposition of the Registrable Securities owned by such Holders;

 

3.1.4 prior to any public offering of Registrable
Securities, use its best efforts to (i) register or qualify the Registrable Securities covered by the Registration Statement under
such securities or “blue sky” laws of such jurisdictions in the United States as the Holders of Registrable Securities included
in such Registration Statement (in light of their intended plan of distribution) may request and (ii) take such action necessary
to cause such Registrable Securities covered by the Registration Statement to be registered with or approved by such other governmental
authorities as may be necessary by virtue of the business and operations of the Company and do any and all other acts and things that
may be necessary or advisable to enable the Holders of Registrable Securities included in such Registration Statement to consummate the
disposition of such Registrable Securities in such jurisdictions; provided, however, that the Company shall not be required
to qualify generally to do business in any jurisdiction where it would not otherwise be required to qualify or take any action to which
it would be subject to general service of process or taxation in any such jurisdiction where it is not then otherwise so subject;

 

3.1.5 cause all such Registrable Securities to be
listed on each securities exchange or automated quotation system on which similar securities issued by the Company are then listed;

 

3.1.6 provide a transfer agent or warrant agent,
as applicable, and registrar for all such Registrable Securities no later than the effective date of such Registration Statement;

 

3.1.7 advise each seller of such Registrable Securities,
promptly after it shall receive notice or obtain knowledge thereof, of the issuance of any stop order by the Commission suspending the
effectiveness of such Registration Statement or the initiation or threatening of any proceeding for such purpose and promptly use its
reasonable best efforts to prevent the issuance of any stop order or to obtain its withdrawal if such stop order should be issued;

 

3.1.8 at least five (5) days prior to the filing
of any Registration Statement or Prospectus or any amendment or supplement to such Registration Statement or Prospectus or any document
that is to be incorporated by reference into such Registration Statement or Prospectus, furnish a copy thereof to each seller of such
Registrable Securities or its counsel;

 

3.1.9 notify the Holders at any time when a Prospectus
relating to such Registration Statement is required to be delivered under the Securities Act, of the happening of any event as a result
of which the Prospectus included in such Registration Statement, as then in effect, includes a Misstatement, and then to correct such
Misstatement as set forth in Section 3.4 hereof;

 

3.1.10 permit a representative of the Holders, the
Underwriters, if any, and any attorney or accountant retained by such Holders or Underwriter to participate, at each such person’s
own expense, in the preparation of the Registration Statement, and cause the Company’s officers, directors and employees to supply
all information reasonably requested by any such representative, Underwriter, attorney or accountant in connection with the Registration;
provided, however, that such representatives or Underwriters enter into a confidentiality agreement, in form and substance
reasonably satisfactory to the Company, prior to the release or disclosure of any such information;

 

3.1.11 in connection with such Registration, including
in the event of (i) an Underwritten Offering, (ii) a Block Trade or (iii) a sale by a broker, placement agent or sales
agent (subject to broker, placement agent or sales agent providing such certification or representation reasonably requested by the Company’s
independent registered public accounts and the Company’s counsel), obtain a “cold comfort” letter from the Company’s
independent registered public accountants, in customary form and covering such matters of the type customarily covered by “cold
comfort” letters and reasonably satisfactory to a majority-in-interest of the participating Holders and the managing Underwriter,
if any, and the applicable broker, placement agent or sales agent, if any, and;

 

     

     

    

 

3.1.12 in connection with such Registration, including
in the event of (i) an Underwritten Offering, (ii) a Block Trade or (iii) a sale by a broker, placement agent or sales
agent, on the date the Registrable Securities are delivered for sale pursuant to such Registration, obtain an opinion and negative assurance
letter, dated such date, of counsel representing the Company for the purposes of such Registration, addressed to the Holders, the broker,
placement agent or sales agent, if any, and the Underwriters, if any, covering such legal matters with respect to the Registration in
respect of which such opinion is being given as the Holders, broker, placement agent, sales agent, or Underwriter may reasonably request
and as are customarily included in such opinions and negative assurance letters, and reasonably satisfactory to a majority in interest
of the participating Holders;

 

3.1.13 in the event of any Underwritten Offering,
enter into and perform its obligations under an underwriting agreement, in usual and customary form, with the managing Underwriter of
such offering;

 

3.1.14 make available to its security holders, as
soon as reasonably practicable, an earnings statement covering the period of at least twelve (12) months beginning with the first day
of the Company’s first full calendar quarter after the effective date of the Registration Statement which satisfies the provisions
of Section 11(a) of the Securities Act and Rule 158 thereunder (or any successor rule promulgated thereafter by the
Commission);

 

3.1.15 if the Registration involves the Registration
of Registrable Securities involving gross proceeds in excess of $50,000,000, use its reasonable efforts to make available senior executives
of the Company to participate in customary “road show” presentations that may be reasonably requested by the Underwriter in
any Underwritten Offering;

 

3.1.16 otherwise, in good faith, cooperate reasonably
with, and take such customary actions as may reasonably be requested by the Holders, in connection with such Registration; and

 

3.1.17 upon request of a Holder, the Company shall
(i) authorize the Company’s transfer agent to remove any legend on share certificates of such Holder’s Common Stock restricting
further transfer (or any similar restriction in book entry positions of such Holder) if such restrictions are no longer required by the
Securities Act or any applicable state securities laws or any agreement with the Company to which such Holder is a party, including if
such shares subject to such a restriction have been sold on a Registration Statement, (ii) request the Company’s transfer agent
to issue in lieu thereof shares of Common Stock without such restrictions to the Holder upon, as applicable, surrender of any stock certificates
evidencing such shares of Common Stock, or to update the applicable book entry position of such Holder so that it no longer is subject
to such a restriction, and (iii) use commercially reasonable efforts to cooperate with such Holder to have such Holder’s shares
of Common Stock transferred into a book-entry position at The Depository Trust Company, in each case, subject to delivery of customary
documentation, including any documentation required by such restrictive legend or book-entry notation.

 

3.2 Registration Expenses. The Registration
Expenses of all Registrations shall be borne by the Company. It is acknowledged by the Holders that the Holders shall bear all incremental
selling expenses relating to the sale of Registrable Securities, such as Underwriters’ commissions and discounts, brokerage fees,
Underwriter marketing costs and, other than as set forth in the definition of “Registration Expenses,” all reasonable
fees and expenses of any legal counsel representing the Holders.

 

3.3 Requirements for Participation in Underwritten
Offerings. No person may participate in any Underwritten Offering for equity securities of the Company pursuant to a Registration
initiated by the Company hereunder unless such person (i) agrees to sell such person’s securities on the basis provided in
any underwriting arrangements approved by the Company and (ii) completes and executes all customary questionnaires, powers of attorney,
indemnities, lock-up agreements, underwriting agreements and other customary documents as may be reasonably required under the terms of
such underwriting arrangements.

 

3.4 Suspension of Sales; Adverse Disclosure.
Upon receipt of written notice from the Company that a Registration Statement or Prospectus contains a Misstatement, each of the Holders
shall forthwith discontinue disposition of Registrable Securities until he, she or it has received copies of a supplemented or amended
Prospectus correcting the Misstatement (it being understood that the Company hereby covenants to prepare and file such supplement or amendment
as soon as practicable after the time of such notice), or until he, she or it is advised in writing by the Company that the use of the
Prospectus may be resumed. If the filing, initial effectiveness or continued use of a Registration Statement in respect of any Registration
at any time would require the Company to make an Adverse Disclosure or would require the inclusion in such Registration Statement of financial
statements that are unavailable to the Company for reasons beyond the Company’s control, the Company may, upon giving prompt written
notice of such action to the Holders, delay the filing or initial effectiveness of, or suspend use of, such Registration Statement for
the shortest period of time, but in no event more than thirty (30) days, determined in good faith by the Company to be necessary for such
purpose. In the event the Company exercises its rights under the preceding sentence, the Holders agree to suspend, immediately upon their
receipt of the notice referred to above, their use of the Prospectus relating to any Registration in connection with any sale or offer
to sell Registrable Securities. The Company shall immediately notify the Holders of the expiration of any period during which it exercised
its rights under this Section 3.4.

 

     

     

    

 

3.5 Reporting Obligations. As long as any
Holder shall own Registrable Securities, the Company, at all times while it shall be a reporting company under the Exchange Act, covenants
to file timely (or obtain extensions in respect thereof and file within the applicable grace period) all reports required to be filed
by the Company after the date hereof pursuant to Sections 13(a) or 15(d) of the Exchange Act and to promptly furnish the Holders
with true and complete copies of all such filings. The Company further covenants that it shall take such further action as any Holder
may reasonably request, all to the extent required from time to time to enable such Holder to sell shares of the Common Stock held by
such Holder without registration under the Securities Act within the limitation of the exemptions provided by Rule 144 promulgated
under the Securities Act (or any successor rule promulgated thereafter by the Commission), including providing any legal opinions,
to the extent such exemption is available to Holders at such time. Upon the request of any Holder, the Company shall deliver to such Holder
a written certification of a duly authorized officer as to whether it has complied with such requirements.

 

3.6 Limitations on Registration Rights. Notwithstanding anything
herein to the contrary, (i) Cantor may not exercise its rights under Sections 2.1 and 2.2 hereunder after five (5) and seven (7) years,
respectively, after the effective date of the registration statement relating to the Company’s initial public offering and (ii)
Cantor may not exercise its rights under Section 2.1 more than one time.

 

ARTICLE IV

INDEMNIFICATION AND CONTRIBUTION

 

4.1 Indemnification.

 

4.1.1 The Company agrees to indemnify, to the extent
permitted by law, each Holder of Registrable Securities, its officers and directors and each person who controls such Holder (within the
meaning of the Securities Act) against all losses, claims, damages, liabilities and expenses (including attorneys’ fees) caused
by any untrue or alleged untrue statement of material fact contained in any Registration Statement, Prospectus or preliminary Prospectus
or any amendment thereof or supplement thereto or any omission or alleged omission of a material fact required to be stated therein or
necessary to make the statements therein not misleading, except insofar as the same are caused by or contained in any information furnished
in writing to the Company by such Holder expressly for use therein. The Company shall indemnify the Underwriters, their officers and directors
and each person who controls such Underwriters (within the meaning of the Securities Act) to the same extent as provided in the foregoing
with respect to the indemnification of the Holder.

 

4.1.2 In connection with any Registration Statement
in which a Holder of Registrable Securities is participating, such Holder shall furnish to the Company in writing such information and
affidavits as the Company reasonably requests for use in connection with any such Registration Statement or Prospectus and, to the extent
permitted by law, shall indemnify the Company, its directors and officers and agents and each person who controls the Company (within
the meaning of the Securities Act) against any losses, claims, damages, liabilities and expenses (including without limitation reasonable
attorneys’ fees) resulting from any untrue statement of material fact contained in the Registration Statement, Prospectus or preliminary
Prospectus or any amendment thereof or supplement thereto or any omission of a material fact required to be stated therein or necessary
to make the statements therein not misleading, but only to the extent that such untrue statement or omission is contained in any information
or affidavit so furnished in writing by such Holder expressly for use therein; provided, however, that the obligation to
indemnify shall be several, not joint and several, among such Holders of Registrable Securities, and the liability of each such Holder
of Registrable Securities shall be in proportion to and limited to the net proceeds received by such Holder from the sale of Registrable
Securities pursuant to such Registration Statement. The Holders of Registrable Securities shall indemnify the Underwriters, their officers,
directors and each person who controls such Underwriters (within the meaning of the Securities Act) to the same extent as provided in
the foregoing with respect to indemnification of the Company.

 

     

     

    

 

4.1.3 Any person entitled to indemnification herein
shall (i) give prompt written notice to the indemnifying party of any claim with respect to which it seeks indemnification (provided
that the failure to give prompt notice shall not impair any person’s right to indemnification hereunder to the extent such failure
has not materially prejudiced the indemnifying party) and (ii) unless in such indemnified party’s reasonable judgment a conflict
of interest between such indemnified and indemnifying parties may exist with respect to such claim, permit such indemnifying party to
assume the defense of such claim with counsel reasonably satisfactory to the indemnified party. If such defense is assumed, the indemnifying
party shall not be subject to any liability for any settlement made by the indemnified party without its consent (but such consent shall
not be unreasonably withheld). An indemnifying party who is not entitled to, or elects not to, assume the defense of a claim shall not
be obligated to pay the fees and expenses of more than one counsel for all parties indemnified by such indemnifying party with respect
to such claim, unless in the reasonable judgment of any indemnified party a conflict of interest may exist between such indemnified party
and any other of such indemnified parties with respect to such claim. No indemnifying party shall, without the consent of the indemnified
party, consent to the entry of any judgment or enter into any settlement which cannot be settled in all respects by the payment of money
(and such money is so paid by the indemnifying party pursuant to the terms of such settlement) or which settlement does not include as
an unconditional term thereof the giving by the claimant or plaintiff to such indemnified party of a release from all liability in respect
to such claim or litigation.

 

4.1.4 The indemnification provided for under this
Agreement shall remain in full force and effect regardless of any investigation made by or on behalf of the indemnified party or any officer,
director or controlling person of such indemnified party and shall survive the transfer of securities. The Company and each Holder of
Registrable Securities participating in an offering also agrees to make such provisions as are reasonably requested by any indemnified
party for contribution to such party in the event the Company’s or such Holder’s indemnification is unavailable for any reason.

 

4.1.5 If the indemnification provided under this
Section 4.1 hereof from the indemnifying party is unavailable or insufficient to hold harmless an indemnified party in respect
of any losses, claims, damages, liabilities and expenses referred to herein, then the indemnifying party, in lieu of indemnifying the
indemnified party, shall contribute to the amount paid or payable by the indemnified party as a result of such losses, claims, damages,
liabilities and expenses in such proportion as is appropriate to reflect the relative fault of the indemnifying party and the indemnified
party, as well as any other relevant equitable considerations. The relative fault of the indemnifying party and indemnified party shall
be determined by reference to, among other things, whether any action in question, including any untrue or alleged untrue statement of
a material fact or omission or alleged omission to state a material fact, was made by, or relates to information supplied by, such indemnifying
party or indemnified party, and the indemnifying party’s and indemnified party’s relative intent, knowledge, access to information
and opportunity to correct or prevent such action; provided, however, that the liability of any Holder under this subsection
4.1.5 shall be limited to the amount of the net proceeds received by such Holder in such offering giving rise to such liability. The
amount paid or payable by a party as a result of the losses or other liabilities referred to above shall be deemed to include, subject
to the limitations set forth in subsections 4.1.1, 4.1.2 and 4.1.3 above, any legal or other fees, charges or expenses
reasonably incurred by such party in connection with any investigation or proceeding. The parties hereto agree that it would not be just
and equitable if contribution pursuant to this subsection 4.1.5 were determined by pro rata allocation or by any other method of
allocation, which does not take account of the equitable considerations referred to in this subsection 4.1.5. No person guilty
of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall be entitled to contribution
pursuant to this subsection 4.1.5 from any person who was not guilty of such fraudulent misrepresentation.

 

     

     

    

 

ARTICLE V

STOCKHOLDER RIGHTS

 

5.1 Subject to the terms and conditions of this
Agreement, at any time and from time to time on or after the date that the Company consummates a Business Combination and for so long
as the Sponsor or the future holders of the Founder Shares (or securities into which the Founder Shares convert), as applicable, holds
any Registrable Securities:

 

5.1.1 The Sponsor and the future holders of the Founder
Shares (or securities into which the Founder Shares convert) held by the Sponsor as of the date hereof shall have the right, but not the
obligation, to designate three (3) individuals to be appointed or nominated, as the case may be, for election to the Board (including
any successor, each, a “Nominee”) by giving written notice to the Company on or before the time such information
is reasonably requested by the Board or the Nominating and Corporate Governance Committee of the Board, as applicable, for inclusion in
a proxy statement for a meeting of stockholders.

 

5.1.2 The Company will, as promptly as practicable,
use its best efforts to take all necessary and desirable actions (including, without limitation, calling special meetings of the Board
and the stockholders and recommending, supporting and soliciting proxies) so that the applicable number of Sponsor Directors is serving
on the Board at all times during which the nomination rights provided in Section 5.1.1 are applicable.

 

5.1.3 The Company shall, to the fullest extent permitted
by applicable law, use its best efforts to take all actions necessary to ensure that: (i) each Nominee is included in the Board’s
slate of nominees to the stockholders of the Company for each election of directors; and (ii) each Nominee is included in the proxy
statement prepared by management of the Company in connection with soliciting proxies for every meeting of the stockholders of the Company
called with respect to the election of members of the Board, and at every adjournment or postponement thereof, and on every action or
approval by written consent of the stockholders of the Company or the Board with respect to the election of members of the Board.

 

5.1.4 If a vacancy occurs because of the death, disability,
disqualification, resignation, or removal of a Sponsor Director or for any other reason during the period in which rights provided in
Section 5.1.1 are applicable, the Sponsor or the future holders of the Founder Shares (or securities into which the Founder Shares
convert), as the case may be, shall be entitled to designate such person’s successor, and the Company will, as promptly as practicable
following such designation, use its best efforts to take all necessary and desirable actions, to the fullest extent permitted by law,
within its control such that such vacancy shall be filled with such successor Nominee.

 

5.1.5 If a Nominee is not elected because of such
Nominee’s death, disability, disqualification, withdrawal as a nominee or for any other reason, the Sponsor or the future holders
of the Founder Shares (or securities into which the Founder Shares convert), as the case may be, shall be entitled to designate promptly
another Nominee and the Company will take all necessary and desirable actions within its control such that the director position for which
such Nominee was nominated shall not be filled pending such designation.

 

5.1.6 As promptly as reasonably practicable following
the request of any Sponsor Director, the Company shall enter into an indemnification agreement with such Sponsor Director, in the form
entered into with the other members of the Board. The Company shall pay the reasonable, documented out-of-pocket expenses incurred by
the Sponsor Director in connection with his or her services provided to or on behalf of the Company, including attending meetings or events
attended explicitly on behalf of the Company at the Company’s request.

 

5.1.7 The Company shall (i) purchase directors’
and officers’ liability insurance in an amount determined by the Board to be reasonable and customary and (ii) for so long
as a Sponsor Director serves as a Director of the Company, maintain such coverage with respect to such Sponsor Director; provided that
upon removal or resignation of such Sponsor Director for any reason, the Company shall take all actions reasonably necessary to extend
such directors’ and officers’ liability insurance coverage for a period of not less than six years from any such event in
respect of any act or omission occurring at or prior to such event.

 

5.1.8 For so long as a Sponsor Director serves as
a director of the Company, the Company shall not amend, alter or repeal any right to indemnification or exculpation covering or benefiting
any director nominated pursuant to this Agreement as and to the extent consistent with applicable law, whether such right is contained
in the Company’s certificate of incorporation or bylaws, each as amended, or another document (except to the extent such amendment
or alteration permits the Company to provide broader indemnification or exculpation rights on a retroactive basis than permitted prior
thereto).

 

     

     

    

 

5.1.9 Any Nominee will be subject to the Company’s
customary due diligence process, including its review of a completed questionnaire and a background check. Based on the foregoing, the
Company may object to any Nominee provided (a) it does so in good faith, and (b) such objection is based upon any of the following:
(i) such Nominee was convicted in a criminal proceeding or is a named subject of a pending criminal proceeding (excluding traffic
violations and other minor offenses), (ii) such Nominee was the subject of any order, judgment, or decree not subsequently reversed,
suspended or vacated of any court of competent jurisdiction, permanently or temporarily enjoining such proposed director from, or otherwise
limiting, the following activities: (A) engaging in any type of business practice, or (B) engaging in any activity in connection
with the purchase or sale of any security or in connection with any violation of federal or state securities laws, (iii) such Nominee
was the subject of any order, judgment or decree, not subsequently reversed, suspended or vacated, of any federal or state authority barring,
suspending or otherwise limiting for more than 60 days the right of such person to engage in any activity described in clause (ii)(B),
or to be associated with persons engaged in such activity, (iv) such proposed director was found by a court of competent jurisdiction
in a civil action or by the Commission to have violated any federal or state securities law, and the judgment in such civil action or
finding by the Commission has not been subsequently reversed, suspended or vacated, or (v) such proposed director was the subject
of, or a party to any federal or state judicial or administrative order, judgment, decree, or finding, not subsequently reversed, suspended
or vacated, relating to a violation of any federal or state securities laws or regulations. In the event the Board reasonably finds the
Nominee to be unsuitable based upon one or more of the foregoing clauses (i) through (v) and reasonably objects to the identified
director, the Sponsor or the future holders of the Founder Shares (or securities into which the Founder Shares convert), as applicable,
shall be entitled to propose a different nominee to the Board within 30 calendar days of the Company’s notice to Sponsor or the
future holders of the Founder Shares (or securities into which the Founder Shares convert), as applicable, of its objection to the Nominee
and such replacement Nominee shall be subject to the review process outlined above.

 

5.1.10 The Company shall take all necessary action
to cause a Sponsor Director chosen by the Sponsor or the future holders of the Founder Shares (or securities into which the Founder Shares
convert), as the case may be, to be elected to the board of directors (or similar governing body) of each material operating subsidiary
of the Company to the extent requested by the Sponsor or the future holders of the Founder Shares (or securities into which the Founder
Shares convert), as applicable. Such Sponsor Director shall have the right to attend (in person or remotely) any meetings of the board
of directors (or similar governing body or committee thereof) of each subsidiary of the Company.

 

ARTICLE VI

MISCELLANEOUS

 

6.1 Notices. Any notice or communication
under this Agreement must be in writing and given by (i) deposit in the United States mail, addressed to the party to be notified,
postage prepaid and registered or certified with return receipt requested, (ii) delivery in person or by courier service providing
evidence of delivery, or (iii) transmission by hand delivery, electronic mail, telecopy, telegram or facsimile. Each notice or communication
that is mailed, delivered, or transmitted in the manner described above shall be deemed sufficiently given, served, sent, and received,
in the case of mailed notices, on the third business day following the date on which it is mailed and, in the case of notices delivered
by courier service, hand delivery, electronic mail, telecopy, telegram or facsimile, at such time as it is delivered to the addressee
(with the delivery receipt or the affidavit of messenger) or at such time as delivery is refused by the addressee upon presentation. Any
notice or communication under this Agreement must be addressed, if to the Company, to: 9001 Burdette Rd., Bethesda, MD 20817, Attention:
Gregory C. Simon, with copy to: Paul Hastings LLP, Paul Hastings LLP, 200 Park Avenue, New York, NY 10166, Attention: Frank Lopez, and,
if to any Holder, at such Holder’s address or facsimile number as set forth in the Company’s books and records. Any party
may change its address for notice at any time and from time to time by written notice to the other parties hereto, and such change of
address shall become effective thirty (30) days after delivery of such notice as provided in this Section 6.1.

 

6.2 Assignment; No Third Party Beneficiaries.

 

6.2.1 This Agreement and the rights, duties and obligations
of the Company hereunder may not be assigned or delegated by the Company in whole or in part.

 

     

     

    

 

6.2.2 Prior to the expiration of the Founder Shares
Lock-Up Period or the Private Placement Lock-Up Period, as the case may be, no Holder may assign or delegate such Holder’s rights,
duties or obligations under this Agreement, in whole or in part, except in connection with a transfer of Registrable Securities by such
Holder to a Permitted Transferee, but only if such Permitted Transferee agrees to become bound by the transfer restrictions set forth
in this Agreement and other applicable agreements.

 

6.2.3 This Agreement and the provisions hereof shall
be binding upon and shall inure to the benefit of each of the parties and its successors and the permitted assigns of the Holders, which
shall include Permitted Transferees.

 

6.2.4 This Agreement shall not confer any rights
or benefits on any persons that are not parties hereto, other than as expressly set forth in this Agreement and Section 6.2
hereof.

 

6.2.5 No assignment by any party hereto of such party’s
rights, duties and obligations hereunder shall be binding upon or obligate the Company unless and until the Company shall have received
(i) written notice of such assignment as provided in Section 6.1 hereof and (ii) the written agreement of the assignee,
in a form reasonably satisfactory to the Company, to be bound by the terms and provisions of this Agreement (which may be accomplished
by an addendum or certificate of joinder to this Agreement). Any transfer or assignment made other than as provided in this Section 6.2
shall be null and void.

 

6.3 Severability. This Agreement shall be
deemed severable, and the invalidity or unenforceability of any term or provision hereof shall not affect the validity or enforceability
of this Agreement or of any other term or provision hereof. Furthermore, in lieu of any such invalid or unenforceable term or provision,
the parties hereto intend that there shall be added as a part of this Agreement a provision as similar in terms to such invalid or unenforceable
provision as may be possible that is valid and enforceable.

 

6.4 Counterparts. This Agreement may be
executed in multiple counterparts (including facsimile or PDF counterparts), each of which shall be deemed an original, and all of which
together shall constitute the same instrument, but only one of which need be produced. A signed copy of this Agreement delivered by facsimile,
e-mail or other means of electronic transmission shall be deemed to have the same legal effect as delivery of an original signed copy
of this Agreement.

 

6.5 Entire Agreement. This Agreement (including
all agreements entered into pursuant hereto and all certificates and instruments delivered pursuant hereto and thereto) constitute the
entire agreement of the parties with respect to the subject matter hereof and supersede all prior and contemporaneous agreements, representations,
understandings, negotiations and discussions between the parties, whether oral or written.

 

6.6 Governing Law; Venue. NOTWITHSTANDING
THE PLACE WHERE THIS AGREEMENT MAY BE EXECUTED BY ANY OF THE PARTIES HERETO, THE PARTIES EXPRESSLY AGREE THAT (I) THIS AGREEMENT
SHALL BE GOVERNED BY AND CONSTRUED UNDER THE LAWS OF THE STATE OF NEW YORK AS APPLIED TO AGREEMENTS AMONG NEW YORK RESIDENTS ENTERED INTO
AND TO BE PERFORMED ENTIRELY WITHIN NEW YORK, WITHOUT REGARD TO THE CONFLICT OF LAW PROVISIONS OF SUCH JURISDICTION AND (II) THE
VENUE FOR ANY ACTION TAKEN WITH RESPECT TO THIS AGREEMENT SHALL BE ANY STATE OR FEDERAL COURT IN NEW YORK COUNTY IN THE STATE OF NEW YORK.

 

6.7 Waiver of Trial by Jury. Each party
hereby irrevocably and unconditionally waives the right to a trial by jury in any action, suit, counterclaim or other proceeding (whether
based on contract, tort or otherwise) arising out of, connected with or relating to this Agreement, the transactions contemplated hereby,
or the actions of the Sponsor in the negotiation, administration, performance or enforcement hereof.

 

6.8 Amendments and Modifications. Upon
the written consent of the Company and the Holders of at least a majority in interest of the Registrable Securities (which majority
interest must include Cantor if such amendment or modification affects in any way the rights of Cantor hereunder) at the time in
question, compliance with any of the provisions, covenants and conditions set forth in this Agreement may be waived, or any of such
provisions, covenants or conditions may be amended or modified; provided, however, that notwithstanding the foregoing, any amendment
hereto or waiver hereof that adversely affects one Holder, solely in his, her or its capacity as a holder of the shares of capital
stock of the Company, in a manner that is materially different from the other Holders (in such capacity) shall require the consent
of the Holder so affected. No course of dealing between any Holder or the Company and any other party hereto or any failure or delay
on the part of a Holder or the Company in exercising any rights or remedies under this Agreement shall operate as a waiver of any
rights or remedies of any Holder or the Company. No single or partial exercise of any rights or remedies under this Agreement by a
party shall operate as a waiver or preclude the exercise of any other rights or remedies hereunder or thereunder by such party.

 

     

     

    

 

6.9 Titles and Headings. Titles and headings
of sections of this Agreement are for convenience only and shall not affect the construction of any provision of this Agreement.

 

6.10 Remedies Cumulative. In the event that
the Company fails to observe or perform any covenant or agreement to be observed or performed under this Agreement, the Holders may proceed
to protect and enforce its rights by suit in equity or action at law, whether for specific performance of any term contained in this Agreement
or for an injunction against the breach of any such term or in aid of the exercise of any power granted in this Agreement or to enforce
any other legal or equitable right, or to take any one or more of such actions, without being required to post a bond. None of the rights,
powers or remedies conferred under this Agreement shall be mutually exclusive, and each such right, power or remedy shall be cumulative
and in addition to any other right, power or remedy, whether conferred by this Agreement or now or hereafter available at law, in equity,
by statute or otherwise.

 

6.11 Other Registration Rights. The Company
represents and warrants that no person, other than a Holder of Registrable Securities, has any right to require the Company to register
any securities of the Company for sale or to include such securities of the Company in any Registration filed by the Company for the sale
of securities for its own account or for the account of any other person. Further, the Company represents and warrants that this Agreement
supersedes any other registration rights agreement or agreement with similar terms and conditions and in the event of a conflict between
any such agreement or agreements and this Agreement, the terms of this Agreement shall prevail.

 

6.12 Term. This Agreement shall terminate
upon the earlier of (i) the tenth anniversary of the date of this Agreement or (ii) the date as of which (A) all of the
Registrable Securities have been sold pursuant to a Registration Statement (but in no event prior to the applicable period referred to
in Section 4(a)(3) of the Securities Act and Rule 174 thereunder (or any successor rule promulgated thereafter by
the Commission)) or (B) the Holders of all of the Registrable Securities are permitted to sell the Registrable Securities under Rule 144
(or any similar provision) under the Securities Act without limitation on the amount of securities sold or the manner of sale. The provisions
of Section 3.5 and Article IV shall survive any termination.

 

[SIGNATURE PAGES FOLLOW]

 

     

     

    

 

IN
WITNESS WHEREOF, the undersigned have caused this Agreement to be executed as of the date first written above.

 

	 	COMPANY:
	 	INTELLIGENT MEDICINE ACQUISITION 

CORP.,
	 	a Delaware corporation
	 	By:	                                                          
	 	Name:	 
	 	Title:	 
	 	 	 
	 	
    HOLDERS:

	 	INTELLIGENT MEDICINE SPONSOR LLC,
	 	a Delaware limited liability company
	 	By:	 
	 	Name:	 
	 	Title:	 

 

[Signature
Page to Registration and Stockholder Rights Agreement]

 

     

     

    

 

	 	
    OTHER HOLDERS:

    

	 	 
	 	 
	 	Gregory C. Simon
	 	 
	 	 
	 	Jack D. Hidary
	 	 
	 	 
	 	Joseph L. Schocken
	 	 
	 	 
	 	Patience Marime-Ball
	 	 
	 	 
	 	Kavita Patel
	 	 
	 	 
	 	Samir N. Khleif, MD
	 	 
	 	 
	 	Geoffrey S. Ling, M.D., Ph.D.
	 	 
	 	 
	 	William A. Haseltine, PhD
	 	 
	 	 
	 	Llew Keltner, MD, PhD
	 	 
	 	 
	 	Jonathan J. Fleming
	 	 
	 	 
	 	Peter S. Knight
	 	 
	 	 
	 	Sue Siegel
	 	 
	 	 
	 	Usama Fayyad

 

 

	 	Cantor
                                            Fitzgerald & Co.
	 	 

		Name:	 
	 	Title:	 

 

[Signature
Page to Registration and Stockholder Rights Agreement]Exhibit
10.1

 

INVESTMENT
AGREEMENT

 

This
INVESTMENT AGREEMENT (the “Agreement”), dated as of May 05, 2021 (the “Execution Date”),
is entered into by and between Sharing Economy International Inc., (the “Company”), a Nevada corporation organized
under the laws of the united States, with its principal executive offices at No. 85 Castle Peak Road Castle Peak Bay, Tuen Mun, N.T.,
Hong Kong, and Strattner Alternative Credit Fund LP (the “Investor”), a Delaware limited partnership company, with
its principal executive offices at 30 Wall Street, 8th Floor, 10005, New York. Each of the Company and the Investor may be referred to
herein as a “Party” and collectively as the “Parties.”

 

RECITALS:

 

A.
The Parties desire that, upon the terms and subject to the conditions contained herein, the Investor shall invest up to Five Million
Dollars ($5,000,000) (the “Commitment Amount”) to purchase the Company’s Common Shares, No par value per
share (the “Common Shares”).

 

A.
Such investments will be made in reliance upon the exemption from securities registration afforded by Section 4(a)(2) of the
Securities Act of 1933, as amended (the “1933 Act”), Rule 506 of Regulation D promulgated by the SEC under the
1933 Act, and/or upon such other exemption from the registration requirements of the 1933 Act as may be available with respect to
any or all of the investments in Common Shares to be made hereunder.

 

A.
Such investments will also be made in reliance upon an exemption from the prospectus requirements of applicable securities laws in
_______________.

 

A.
Contemporaneously with the execution and delivery of this Agreement, the parties hereto are executing and delivering a Registration
Rights Agreement substantially in the form attached hereto as Exhibit A (the “Registration Rights
Agreement”) pursuant to which the Company has agreed to provide certain registration rights under the 1933 Act, and the
rules and regulations promulgated thereunder, and applicable state securities laws.

 

AGREEMENT

 

NOW
THEREFORE, in consideration of the foregoing recitals, which shall be considered an integral part of this Agreement, the covenants and
agreements set forth hereafter, and other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged,
the Company and the Investor hereby agree as follows:

 

SECTION
I.

DEFINITIONS

 

For
all purposes of and under this Agreement, the following terms shall have the respective meanings below, and such meanings shall be equally
applicable to the singular and plural forms of such defined terms.

 

“1933
Act” shall have the meaning set forth in the recitals.

 

“1934
Act” shall mean the Securities Exchange Act of 1934, as amended, or any similar federal statute, and the rules and regulations
of the SEC thereunder, all as the same will then be in effect.

 

“Affiliate” shall mean any individual or entity that, directly or indirectly through one or more intermediaries, controls
or is controlled by or is under common control with another individual or entity as such terms are used in and construed under Rule 405
under the 1933 Act.

 

“Agreement”
shall have the meaning set forth in the preamble.

 

“Articles
of Incorporation” shall have the meaning set forth in Section 4.3.

 

     

     

    

 

“By-laws”
shall have the meaning set forth in Section 4.3.

 

“Certificate”
shall have the meaning set forth in Section 2.6.

 

“Closing”
shall have the meaning set forth in Section 2.6.

 

“Closing
Date” shall have the meaning set forth in Section 2.6.

 

“Commitment
Amount” shall have the meaning set forth in the recitals.

 

“Commitment
Fee Shares” shall have the meaning set forth in Section 10.17.

 

“Common
Shares” shall have the meaning set forth in the recitals.

 

“Company”
shall have the meaning set forth in the preamble.

 

“DTC”
shall have the meaning set forth in Section 2.5.

 

“DWAC”
shall mean Deposit and Withdrawal at Custodian service provided by the Depository Trust Company.

 

“Effective
Date” shall mean the date the SEC declares effective under the 1933 Act the Registration Statement covering the Securities.

 

“Execution
Date” shall have the meaning set forth in the preamble.

 

“S-1
Filing Deadline” shall have the meaning set forth in Section 10.17.

 

“FAST”
shall have the meaning set forth in Section 2.5.

 

“Investor”
shall have the meaning set forth in the preamble.

 

“Material
Adverse Effect” shall have the meaning set forth in Section 4.1.

 

“Maximum
Common Share Issuance” shall have the meaning set forth in Section 2.67.

 

“Open
Period” shall mean the period beginning on and including the Trading Day immediately following the Effective Date and ending
on the earlier to occur of (i) the date which is thirty-six (36) months from the Effective Date; or (ii) termination of the Agreement
in accordance with Section 8.

 

“PCAOB”
shall have the meaning set forth in Section 4.6.

 

“Pricing
Period” shall mean, with respect to a particular Put Notice, the five (5) consecutive Trading Days including and immediately
following the applicable Put Notice Date.

 

“Principal
Market” shall mean the New York Stock Exchange, the NYSE MKT, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq
Global Select Market, the OTC Bulletin Board or the OTC Markets Group, whichever is the principal market on which the Common Shares are
traded.

 

“Purchase
Amount” shall mean the total amount being paid by the Investor on a particular Closing Date to purchase the Securities, calculated
by multiplying the Purchase Price by the Put Amount.

 

    2

     

    

 

“Purchase
Price” shall mean the 85% of the lowest VWAP (defined below) of the Common Shares during the Pricing Period applicable to the
Put Notice, provided, however, an additional 10% will be added to the discount of each Put if (i) the Company is not DWAC eligible and
(ii) an additional 15% will be added to the discount of each Put if the Company is under DTC “chill” status on the applicable
Put Notice Date.

 

“Put”
shall have the meaning set forth in Section 2.2.

 

“Put
Amount” shall have the meaning set forth in Section 2.3.

 

“Put
Notice” shall mean a written notice sent to the Investor by the Company stating the Put Amount in U.S. dollars that the Company
intends to sell to the Investor pursuant to the terms of the Agreement and stating the current number of Shares issued and outstanding
on such date.

 

“Put
Notice Date” shall mean the Trading Day on which the Investor receives a Put Notice, determined as follows: a Put Notice shall
be deemed delivered on (a) the Trading Day it is received by electronic mail or otherwise by the Investor if such notice is received
prior to 9:30 a.m. (Pacific time), or (b) the immediately succeeding Trading Day if it is received by electronic mail or otherwise after
9:30 a.m. (Pacific time) on a Trading Day. No Put Notice may be deemed delivered on a day that is not a Trading Day.

 

“Put
Settlement Sheet” shall mean a written letter to the Company by the Investor, evidencing acceptance of the Put and providing
instructions for delivery of the Securities to the Investor.

 

“Put
Shares Due” shall mean the Shares to be sold to the Investor pursuant to the Put.

 

“Registered
Offering Transaction Documents” shall mean this Agreement and the Registration Rights Agreement between the Company and the
Investor as of the date herewith.

 

“Registration
Rights Agreement” shall have the meaning set forth in the recitals.

 

“Registration
Statement” or “S-1” means the registration statement of the Company filed under the 1933 Act covering the
resale of the Securities issuable hereunder to the Investor, in the manner described in such Registration Statement.

 

“Resolutions”
shall have the meaning set forth in Section 7.5.

 

“SEC”
shall mean the U.S. Securities and Exchange Commission.

 

“SEC
Documents” shall have the meaning set forth in Section 4.6.

 

“Securities”
shall mean the Common Shares issued pursuant to the terms of the Agreement.

 

“Shares”
shall mean the Common Shares of the Company.

 

“Trading
Day” shall mean any day on which the Principal Market for the Common Shares is open for trading, from the hours of 9:30 am
until 4:00 pm.

 

“VWAP”
shall mean, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Shares are then
listed or quoted on a Trading Market, the daily volume weighted average price of the Common Shares for such date (or the nearest preceding
date) on the Trading Market on which the Common Shares are then listed or quoted for trading as reported by (i) Bloomberg Financial L.P.
or (ii) Stock Charts/Quote Media if the Investor does not promptly provide the Company the Bloomberg quote/pricing charts for the days
involved upon the Company’s request (based on a Trading Day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time))
and (b) in all other cases, the fair market value of a Common Share as determined by an independent appraiser selected in good faith
by the Investor and to the Company.

 

    3

     

    

 

“Waiting
Period” shall have the meaning set forth in Section 2.3.

 

SECTION
II

PURCHASE
AND SALE OF COMMON SHARES

 

2.1 PURCHASE AND SALE OF COMMON SHARES. Subject to the terms and conditions set forth herein, the Company may issue and sell to
the Investor, and the Investor shall purchase from the Company, up to that number of Shares having an aggregate Purchase Price of Five
Million Dollars ($5,000,000).

 

2.2
DELIVERY OF PUT NOTICES. Subject to the terms and conditions of the Registered Offering Transaction Documents, and from time to
time during the Open Period, the Company may, in its sole discretion, deliver to the Investor: (i) a Put Notice which states the share
amount (designated in whole Common Shares of the Company), which the Company intends to sell to the Investor on a Closing date (the “Put”),
and (ii) an issuance resolution, which shall be in the form as required by the Company’s transfer agent. The Put Notice shall be
in the form attached hereto as Exhibit B and incorporated herein by reference. The Investor shall deliver to the Company a Put
Settlement Sheet on each applicable Closing Date. The Put Settlement Sheet shall be in the form attached hereto as Exhibit C and
incorporated herein by reference.

 

2.3
PUT FORMULA. The maximum amount of Common Shares that the Company shall be entitled to Put to the Investor per any applicable
Put Notice shall be an amount of shares up to or equal to two hundred percent (200%) of the average of the daily trading volume of the
Common Shares for the ten (10) consecutive Trading Days immediately prior to the applicable Put Notice Date (the “Put Amount”)
so long as such amount is at least Five Thousand Dollars ($5,000) and does not exceed Two Hundred Fifty Thousand Dollars ($250,000),
as calculated by multiplying the Put Amount by the average daily VWAP for the ten (10) consecutive Trading Days immediately prior to
the applicable Put Notice Date. During the Open Period, the Company shall not be entitled to submit a Put Notice until after the previous
Closing has been completed. Notwithstanding the foregoing, the Company may not deliver a Put Notice on or earlier of the tenth (10th)
Trading Day immediately following the preceding Put Notice Date (the “Waiting Period”), unless a written waiver to
deliver Put Notice during the Waiting Period is obtained by the Company from the Investor in advance.

 

2.4
CONDITIONS TO INVESTOR’S OBLIGATION TO PURCHASE SHARES. Notwithstanding anything to the contrary in this Agreement, the
Company shall not be entitled to deliver a Put Notice and the Investor shall not be obligated to purchase any Shares at a Closing unless
each of the following conditions are satisfied:

 

i.
a Registration Statement shall have been declared effective and shall remain effective, usable and available for the resale of
all the Put Shares Due at all times until the Closing with respect to the applicable Put Notice;

 

ii.
at all times during the period beginning on the related Put Notice Date and ending on and including the related Closing Date, the
Common Shares shall have been listed or quoted for trading on the Principal Market and shall not have been suspended from trading
thereon during the Pricing Period (excluding suspensions of not more than one (1) Trading Day resulting from business announcements
by the Company, provided that such suspensions occur prior to the Company’s delivery of a Put Notice);

 

iii.
the Company has complied with its obligations and is otherwise not in material breach of or in material default under, this
Agreement, the Registration Rights Agreement or any other agreement executed in connection herewith which has not been cured prior
to delivery to the Investor of the applicable Put Notice;

 

iv.
No injunction shall have been issued and remain in force, or action commenced by a governmental authority which has not been stayed
or abandoned, prohibiting the purchase or the issuance of the Securities; and

 

v.
the issuance of the Securities will not violate any shareholder approval requirements of the Principal Market.

 

    4

     

    

 

If
any of the events described in clauses (i) through (v) above occurs during a Pricing Period, then the Investor shall have No obligation
to purchase the Put Amount of Common Shares set forth in the applicable Put Notice.

 

2.5 MECHANICS
OF PURCHASE OF SHARES BY INVESTOR. If the Company’s transfer agent is participating in the Depository Trust Company
(“DTC”) Fast Automated Securities Transfer (“FAST”) program, and the Securities are eligible
for inclusion in the FAST program, the Company shall use all commercially reasonable efforts to cause its transfer agent to
electronically transmit the Securities to the Investor within one (1) Trading Day following delivery by the Company of a Put Notice
by crediting the account of the Investor’s prime broker, as specified by the Investor, with DTC through its DWAC or DRS
service. If the Company is not DWAC or DRS eligible or the Company is under DTC “chill” on such Closing Date (defined
below), the Company shall deliver to the Investor pursuant to this Agreement, certificate or certificates representing the
Securities to be issued to the Investor on such date and registered in the name of the Investor (the
“Certificate”). Subject to the satisfaction of the conditions set forth in Sections 2.6 and 7 of this
Agreement, the closing of the purchase by the Investor of Securities (a “Closing”) shall occur on the date which
is No earlier than five (5) Trading Days following and No later than seven (7) Trading Days following the applicable Put Notice Date
(each, a “Closing Date”). On such Closing, but not prior to receipt of confirmation of delivery of such
Securities to the Investor, the Investor shall disburse the funds constituting the Purchase Amount to an account designated by the
Company by wire transfer of (i) immediately available funds if the Investor receives the Securities by 10:00 a.m. (Pacific time) or
(ii) next day available funds if the Investor receives the Securities thereafter.

 

2.6
OVERALL LIMIT ON COMMON SHARES ISSUABLE. Notwithstanding anything contained herein to the contrary, if during the Open Period
the Company becomes listed on an exchange that limits the number of Common Shares that may be issued without shareholder approval, if
applicable, then the number of Shares issuable by the Company and purchasable by the Investor, shall not exceed that number of the Common
Shares that may be issuable without shareholder approval (the “Maximum Common Share Issuance”). If such issuance of
Common Shares could cause a delisting on the Principal Market, then the Maximum Common Share Issuance shall first be approved by the
Company’s shareholders in accordance with applicable law and the By-laws and the Articles of Incorporation of the Company, if
such issuance of shares of Common Share could cause a delisting on the Principal Market. The parties understand and agree that the Company’s
failure to seek or obtain such shareholder approval shall in No way adversely affect the validity and due authorization of the issuance
and sale of Securities or the Investor’s obligation in accordance with the terms and conditions hereof to purchase a number of
Shares in the aggregate up to the Maximum Common Share Issuance limitation, and that such approval pertains only to the applicability
of the Maximum Common Share Issuance limitation provided in this Section 2.6.

 

2.7
LIMITATION ON AMOUNT OF OWNERSHIP. Notwithstanding anything to the contrary in this Agreement, in No event shall the Investor
be entitled to purchase that number of Shares, which when added to the sum of the number of Common Shares beneficially owned (as such
term is defined under Section 13(d) and Rule 13d-3 of the 1934 Act), by the Investor, would exceed 9.99% of the number of Common Shares
outstanding on the Closing Date, as determined in accordance with Rule 13d-1(j) of the 1934 Act.

 

SECTION
III

INVESTOR’S
REPRESENTATIONS, WARRANTIES AND COVENANTS

 

The
Investor represents and warrants to the Company, and covenants, that:

 

3.1 SOPHISTICATED INVESTOR. The Investor has, by reason of its business and financial experience, such knowledge, sophistication
and experience in financial and business matters and in making investment decisions of this type that it is capable of (i) evaluating
the merits and risks of an investment in the Securities and making an informed investment decision, and has so evaluated the merits and
risks of such investment; (ii) protecting its own interest; and (iii) bearing the economic risk of such investment for an indefinite
period of time. The Investor is not resident in Australia, it is not formed under the laws of Australia or any of its provinces or territories,
and does not have a physical or operational presence in Australia other than occasional investments in publicly traded companies from
time to time.

 

    5

     

    

 

3.2
AUTHORIZATION; ENFORCEMENT. This Agreement and the purchase by the Investor of the Securities hereunder has been duly and validly
authorized, executed and delivered on behalf of the Investor and constitutes the valid and binding agreement of the Investor enforceable
against the Investor in accordance with its terms, subject as to enforceability to general principles of equity and to applicable bankruptcy,
insolvency, reorganization, moratorium, liquidation and other similar laws relating to, or affecting generally, the enforcement of applicable
creditors ’rights and remedies.

 

3.3
SECTION 9 OF THE 1934 ACT. During the term of this Agreement, the Investor will comply with the provisions of Section 9 of the
1934 Act, and the rules promulgated thereunder, with respect to transactions involving the Common Shares. The Investor agrees not to
short sell or hedge the Company’s stock either directly or indirectly through its affiliates, parent or subsidiary companies, principals
or advisors, the Common Shares during the term of this Agreement. The Investor will only sell Company stock that it has in its possession.

 

3.4
ACCREDITED INVESTOR. The Investor is an “accredited investor” as that term is defined in Rule 501(a) of Regulation
D of the 1933 Act or a “qualified institutional buyer” as defined in Rule 144A(a) under the 1933 Act, and has completed and
provided to the Company the U.S. Accredited Investor Certificate, as set forth on Exhibit D to this Agreement. Investor is not
a “disqualified investor” by virtue of the investor being subject to a “disqualifying event” as defined under
Rule 506(b) through (e) of Regulation D of the 1933 Act as amended.

 

3.5
UNDERWRITER STATUS. The Investor is deemed an “underwriter” (as that term is defined in Section 2(a)(11) of the Securities
Act) in connection with the registration of the Registrable Securities and will be identified as such in the Registration Statement.
As an underwriter, the Investor will not have Rule 144 of the Securities Act available as a resale exemption from registration under
the U.S. securities laws.

 

3.6
No CONFLICTS. The execution, delivery and performance of the Registered Offering Transaction Documents by the Investor and the
consummation by the Investor of the transactions contemplated hereby and thereby will not (i) result in a violation of limited liability
company agreement or other organizational documents of the Investor and/or (ii) result in a violation of any law, rule, regulation,
order, judgment or decree (including federal and state securities laws) applicable to such Investor, except in the case of this clause
(ii), for such that are not material and do not otherwise affect the ability of such Investor to consummate the transactions contemplated
hereby. The business of the Investor is not being conducted, and shall not be conducted, in violation of any law, statute, ordinance,
rule, order or regulation of any governmental authority or agency, regulatory or self-regulatory agency, or court, except for violations
the sanctions for which either, individually or in the aggregate, would not have or reasonably be expected to have a material adverse
effect on the Investor. Except as specifically contemplated by this Agreement and as required under the 1933 Act or any securities laws
of any states, to the Investor’s knowledge, the Investor is not required to obtain any consent, authorization, permit or order
of, or make any filing or registration (except the filing of a registration statement as outlined in the Registration Rights Agreement)
with, any court, governmental authority or agency, regulatory or self-regulatory agency or other third party in order for it to execute,
deliver or perform any of its obligations under, or contemplated by, the Registered Offering Transaction Documents in accordance with
the terms hereof or thereof except for those consents, authorizations, permits, orders or filings as have been obtained or effected on
or prior to the date hereof and are in full force and effect as of the date hereof.

 

3.7
OPPORTUNITY TO DISCUSS. The Investor has had access to and received all materials and information relating to the Company’s
business, finance and operations which it has requested. The Investor has had an opportunity to discuss the business, management and
financial affairs of the Company with the Company’s management in order to evaluate the merits and risks of investing in the Securities.

 

3.8
INVESTMENT PURPOSES. The Investor is purchasing the Securities for its own account for investment purposes and not with a view
towards distribution and agrees to resell or otherwise dispose of the Securities solely in accordance with the registration provisions
of the 1933 Act (or pursuant to an exemption from such registration provisions) and in compliance with applicable federal and state
securities laws.

 

    6

     

    

 

3.9
No REGISTRATION AS A DEALER. The Investor is not engaged in the business of being a broker-dealer and will not be required to
be registered as a “dealer” under the 1934 Act, either as a result of its execution and performance of its obligations under
this Agreement or otherwise.

 

3.10
GOOD STANDING. The Investor is a limited liability company, duly organized, validly existing and in good standing in the State
of Wyoming with the requisite corporate, partnership or other power and authority to enter into and to consummate the transactions contemplated
by this Agreement and otherwise to carry out its obligations hereunder and thereunder.

 

3.11
TAX LIABILITIES. The Investor understands that it is liable for its own tax liabilities and that nothing in this Agreement or
any other materials presented by or on behalf of the Company to the Investor in connection with the purchase of the Securities constitutes
legal, tax or investment advice.

 

3.12
REGULATION M. The Investor will comply and be solely responsible with the requirements of Regulation M under the 1934 Act, if
applicable.

 

3.13
GENERAL SOLICITATION. The Investor is not purchasing the Securities as a result of any advertisement, article, notice or other
communication regarding the Securities published in any newspaper, magazine or similar media or broadcast over television or radio or
presented at any seminar or any other general solicitation or general advertisement.

 

3.14
TRANSFER RESTRICTIONS. The Securities may only be disposed of in compliance with federal and state securities laws of the United
States. In connection with any transfer of Securities, other than pursuant to an effective registration statement, to the Company or
to an affiliate of the Investor, the Company may require the transferor thereof to provide to the Company an opinion of counsel selected
by the transferor and reasonably acceptable to the Company, the form and substance of which opinion shall be reasonably satisfactory
to the Company, to the effect that such transfer does not require registration of such transferred Securities under the 1933 Act. As
a condition of transfer, any such transferee shall agree in writing to be bound by the terms of this Agreement and shall have the rights
of the Investor under this Agreement and the Registration Rights Agreement, as to issued Securities only.

 

SECTION
IV

REPRESENTATIONS
AND WARRANTIES OF THE COMPANY

 

Except
as set forth in the Schedules attached hereto, or as disclosed on the Company’s SEC Documents, the Company represents and
warrants to the Investor that:

 

4.1
ORGANIZATION AND QUALIFICATION. The Company is a corporation duly organized and validly existing in good standing under applicable
laws of ___________________ and has the requisite corporate power and authorization to own its properties and to carry on its business
as now being conducted. The Company is duly qualified to do business and is in good standing in every jurisdiction in which its ownership
of property or the nature of the business conducted by it makes such qualification necessary, except to the extent that the failure to
be so qualified or be in good standing would not have a Material Adverse Effect. As used in this Agreement, “Material Adverse
Effect ” means a change, event, circumstance, effect or state of facts that has had or is reasonably likely to have, a material
adverse effect on the business, properties, assets, operations, results of operations, financial condition or prospects of the Company,
if any, taken as a whole, or on the transactions contemplated hereby or by the agreements and instruments to be entered into in connection
herewith, or on the authority or ability of the Company to perform its obligations under the Registered Offering Transaction Documents.

 

    7

     

    

 

4.2 AUTHORIZATION;
ENFORCEMENT; COMPLIANCE WITH OTHER INSTRUMENTS.

 

i.
The Company has the requisite corporate power and authority to enter into and perform the Registered Offering Transaction Documents,
and to issue the Securities in accordance with the terms hereof and thereof.

 

ii.
The execution and delivery of the Registered Offering Transaction Documents by the Company and the consummation by it of the
transactions contemplated hereby and thereby, including without limitation the issuance of the Securities pursuant to this
Agreement, have been duly and validly authorized by the Company’s board of directors and No further consent or authorization
is required by the Company, its board of directors, or its shareholders.

 

iii.
The Registered Offering Transaction Documents have been duly and validly executed and delivered by the Company.

 

iv.
The Registered Offering Transaction Documents constitute the valid and binding obligations of the Company enforceable against the
Company in accordance with their terms, except as such enforceability may be limited by general principles of equity or applicable
bankruptcy, insolvency, reorganization, moratorium, liquidation or similar laws relating to, or affecting generally, the
enforcement of creditors ’rights and remedies.

 

4.3
CAPITALIZATION. As of the date hereof, the authorized capital stock of the Company consists of an _____________________ shares
of common stock, __________ par value per share, of which __________ were issued and outstanding as of March ___, 2021. All of such outstanding
shares have been, or upon issuance will be, validly issued and are fully paid and non-assessable.

 

Except
as disclosed in the Company’s publicly available filings with the SEC, or as otherwise set forth on Schedule 4.3:

 

i.
No shares of the Company’s capital stock are subject to preemptive rights or any other similar rights or any liens or
encumbrances suffered or permitted by the Company;

 

ii.
there are no outstanding debt securities;

 

iii.
there are no outstanding shares of capital stock, options, warrants, scrip, rights to subscribe to, calls or commitments of any
character whatsoever relating to, or securities or rights convertible into, any shares of capital stock of the Company, or
contracts, commitments, understandings or arrangements by which the Company is or may become bound to issue additional shares of
capital stock of the Company or options, warrants, scrip, rights to subscribe to, calls or commitments of any character whatsoever
relating to, or securities or rights convertible into, any shares of capital stock of the Company;

 

iv.
there are no agreements or arrangements under which the Company is obligated to register the sale of any of their securities under
the 1933 Act (except the Registration Rights Agreement);

 

v.
there are no outstanding securities of the Company which contain any redemption or similar provisions, and there are no contracts,
commitments, understandings or arrangements by which the Company is or may become bound to redeem a security of the
Company;

vi.
there are no securities or instruments containing anti-dilution or similar provisions that will be triggered by the issuance of the
Securities as described in this Agreement;

 

vii.
the Company does not have any stock appreciation rights or “phantom stock” plans or agreements or any similar plan or
agreement; and

 

viii.
there is no dispute as to the classification of any shares of the Company’s capital stock.

 

The
Company has furnished to the Investor true and correct copies of the Company’s Articles of Incorporation, as in effect on the date
hereof (the “Articles of Incorporation”), and the Company’s By-laws, as in effect on the date hereof (the “By-laws”), and the terms of all securities convertible into or exercisable for Common Shares and the material rights of the holders
thereof in respect thereto.

 

4.4
ISSUANCE OF SHARES. The Company is authorized to issue an unlimited numbers of common shares voting and participating, without
par value per share. Upon issuance in accordance with this Agreement, the Securities will be validly issued, fully paid for and non-assessable
and free from all taxes, liens and charges with respect to the issue thereof.

 

    8

     

    

 

4.5
NO CONFLICTS. The execution, delivery and performance of the Registered Offering Transaction Documents by the Company and the
consummation by the Company of the transactions contemplated hereby and thereby will not (i) result in a violation of the Articles of
Incorporation or the By-laws; or (ii) conflict with, or constitute a material default (or an event which with notice or lapse of time
or both would become a material default) under, or give to others any rights of termination, amendment, acceleration or cancellation
of, any material agreement, contract, indenture mortgage, indebtedness or instrument to which the Company is a party, or to the Company’s
knowledge result in a violation of any law, rule, regulation, order, judgment or decree (including United States federal and state securities
laws and regulations and the rules and regulations of the Principal Market or principal securities exchange or trading market on which
the Common Shares are traded or listed) applicable to the Company or by which any property or asset of the Company is bound or affected.
The Company is not in violation of any term of, or in default under, the Articles of Incorporation or the By-laws or its organizational
charter or by-laws, respectively, or any contract, agreement, mortgage, indebtedness, indenture, instrument, judgment, decree or order
or any statute, rule or regulation applicable to the Company, except for possible conflicts, defaults, terminations, amendments, accelerations,
cancellations and violations that would not individually or in the aggregate have or constitute a Material Adverse Effect. To the knowledge
of the Company, the business of the Company is not being conducted, and shall not be conducted, in violation of any law, statute, ordinance,
rule, order or regulation of any governmental authority or agency, regulatory or self-regulatory agency, or court, except for possible
violations the sanctions for which either individually or in the aggregate would not be likely to have a Material Adverse Effect. Except
as specifically contemplated by this Agreement and as required under the 1933 Act, any securities laws of any states, or any other jurisdiction
to which the Company is subject, to the Company’s knowledge, the Company is not required to obtain any consent, authorization,
permit or order of, or make any filing or registration (except the filing of a registration statement as outlined in the Registration
Rights Agreement between the parties) with, any court, governmental authority or agency, regulatory or self-regulatory agency or other
third party in order for it to execute, deliver or perform any of its obligations under, or contemplated by, the Registered Offering
Transaction Documents in accordance with the terms hereof or thereof, except for the filing with and approval of the Registration Statement
with the SEC. All consents, authorizations, permits, orders, filings and registrations which the Company is required to obtain pursuant
to the preceding sentence have been obtained or effected on or prior to the date hereof and are in full force and effect as of the date
hereof. The Company is unaware of any facts or circumstances which might give rise to any of the foregoing. The Company is not, and will
not be, in violation of the listing requirements of the Principal Market as in effect on the date hereof and on each of the Closing Dates
and is not aware of any facts which would reasonably lead to delisting of the Common Shares by the Principal Market in the foreseeable
future.

 

4.
6 SEC DOCUMENTS; FINANCIAL STATEMENTS. As of the date hereof, the Company has filed all reports, schedules, forms, statements
and other documents required to be filed by it with the SEC pursuant to the reporting requirements of the 1934 Act (all of the foregoing
filed prior to the date hereof and all exhibits included therein and financial statements and schedules thereto and documents incorporated
by reference therein, and amendments thereto, being hereinafter referred to as the “SEC Documents”). The Company
has delivered to the Investor or its representatives, or they have had access through EDGAR to true and complete copies of the SEC Documents.
As of their respective filing dates, the SEC Documents complied in all material respects with the requirements of the 1934 Act and the
rules and regulations of the SEC promulgated thereunder applicable to the SEC Documents, and none of the SEC Documents, at the time they
were filed with the SEC or the time they were amended, if amended, contained any untrue statement of a material fact or omitted to state
a material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances under which
they were made, not misleading. As of their respective dates, the financial statements of the Company included in the SEC Documents complied
as to form in all material respects with applicable accounting requirements and the published rules and regulations of the SEC with respect
thereto. Such financial statements have been prepared in accordance with the International Financial Reporting Standards, by a firm that
is a member of the Public Companies Accounting Oversight Board (“PCAOB”) consistently applied, during the periods
involved (except (i) as may be otherwise indicated in such financial statements or the notes thereto, or (ii) in the case of unaudited
interim statements, to the extent they may exclude footnotes or may be condensed or summary statements) and fairly present in all material
respects the financial position of the Company as of the dates thereof and the results of its operations and cash flows for the periods
then ended (subject, in the case of unaudited statements, to normal year-end audit adjustments). No other written information provided
by or on behalf of the Company to the Investor which is not included in the SEC Documents, including, without limitation, information
referred to in Section 4.3 of this Agreement, contains any untrue statement of a material fact or omits to state any material
fact necessary to make the statements therein, in the light of the circumstance under which they are or were made, not misleading. To
the Company’s knowledge, neither it nor any of its officers, directors, employees or agents have provided the Investor with any
material, nonpublic information which was not publicly disclosed prior to the date hereof and any material, nonpublic information provided
to the Investor by the Company or any of their officers, directors, employees or agents prior to any Closing Date shall be publicly disclosed
by the Company prior to such Closing Date.

 

    9

     

    

 

4.7
ABSENCE OF CERTAIN CHANGES. Except as otherwise set forth in the SEC Documents and/or any press releases, the Company does not
intend to change the business operations of the Company in any material way. The Company has not taken any steps, and does not currently
expect to take any steps, to seek protection pursuant to any bankruptcy law nor does the Company have any knowledge or reason to believe
that its creditors intend to initiate involuntary bankruptcy proceedings.

 

4.8
ABSENCE OF LITIGATION AND/OR REGULATORY PROCEEDINGS. Except as set forth in the SEC Documents, there is No action, suit, proceeding,
inquiry or investigation before or by any court, public board, government agency, self-regulatory organization or body pending or, to
the knowledge of the executive officers of Company, threatened against or affecting the Company, the Common Shares or any of the Company
’s officers or directors in their capacities as such, in which an adverse decision could have a Material Adverse Effect.

 

4.9 ACKNOWLEDGMENT
REGARDING INVESTOR’S PURCHASE OF SHARES. The Company acknowledges and agrees that the Investor is acting solely in the
capacity of an arm’s length purchaser with respect to the Registered Offering Transaction Documents and the transactions
contemplated hereby and thereby. The Company further acknowledges that the Investor is not acting as a financial advisor or
fiduciary of the Company (or in any similar capacity) with respect to the Registered Offering Transaction Documents and the
transactions contemplated hereby and thereby and any advice given by the Investor or any of its respective representatives or agents
in connection with the Registered Offering Transaction Documents and the transactions contemplated hereby and thereby is merely
incidental to the Investor’s purchase of the Securities, and is not being relied on by the Company. The Company further
represents to the Investor that the Company’s decision to enter into the Registered Offering Transaction Documents has been
based solely on the independent evaluation by the Company and its representatives.

 

4.
10 NO UNDISCLOSED EVENTS, LIABILITIES, DEVELOPMENTS OR CIRCUMSTANCES. Except as set forth in the SEC Documents or required with
respect to the Registered Offering Transaction Documents, as of the date hereof, No event, liability, development or circumstance has
occurred or exists, or to the Company’s knowledge is contemplated to occur, with respect to the Company or its business, properties,
assets, prospects, operations or financial condition, that would be required to be disclosed by the Company under applicable securities
laws on a registration statement filed with the SEC relating to an issuance and sale by the Company of its Common Shares and which has
not been publicly announced.

 

4.11
EMPLOYEE RELATIONS. The Company is not involved in any union labor dispute nor, to the knowledge of the Company, is any such dispute
threatened. The Company is not a party to a collective bargaining agreement, and the Company believes that relations with its employees
are good. No executive officer (as defined in Rule 501(f) of the 1933 Act) has notified the Company that such officer intends to leave
the Company’s employ or otherwise terminate such officer’s employment with the Company.

 

4.12
INTELLECTUAL PROPERTY RIGHTS. The Company owns or possess adequate rights or licenses to use all trademarks, trade names, service
marks, service mark registrations, service names, patents, patent rights, copyrights, inventions, licenses, approvals, governmental authorizations,
trade secrets and rights necessary to conduct their respective businesses as now conducted. Except as set forth in the SEC Documents,
none of the Company’s trademarks, trade names, service marks, service mark registrations, service names, patents, patent rights,
copyrights, inventions, licenses, approvals, government authorizations, trade secrets or other intellectual property rights necessary
to conduct its business as now or as proposed to be conducted have expired or terminated, or are expected to expire or terminate within
two (2) years from the date of this Agreement, except as to certain trademarks that may remain pending. The Company does not have any
knowledge of any infringement by the Company of trademark, trade name rights, patents, patent rights, copyrights, inventions, licenses,
service names, service marks, service mark registrations, trade secret or other similar rights of others, or of any such development
of similar or identical trade secrets or technical information by others and, except as set forth in the SEC Documents, there is No claim,
action or proceeding being made or brought against, or to the Company’s knowledge, being threatened against, the Company regarding
trademark, trade name, patents, patent rights, invention, copyright, license, service names, service marks, service mark registrations,
trade secret or other infringement; and the Company is unaware of any facts or circumstances which might give rise to any of the foregoing.
The Company has taken commercially reasonable security measures to protect the secrecy, confidentiality and value of all of its intellectual
properties.

 

    10

     

    

 

4.13 [Reserved].

 

4.14
TITLE. The Company has good and marketable title to all personal property owned by it which is material to the business of the
Company, free and clear of all liens, encumbrances and defects except such as are described in the SEC Documents or such as do not materially
affect the value of such property and do not interfere with the use made and proposed to be made of such property by the Company. Any
real property and facilities held under lease by the Company is held by it under valid, subsisting and enforceable leases with such exceptions
as are not material and do not interfere with the use made and proposed to be made of such property and buildings by the Company.

 

4.15
INSURANCE. The Company is insured by insurers of recognized financial responsibility against such losses and risks and in such
amounts as management of the Company reasonably believes to be prudent and customary in the businesses in which the Company is engaged.
The Company has not been refused any insurance coverage sought or applied for and the Company has No reason to believe that it will not
be able to renew its existing insurance coverage as and when such coverage expires or to obtain similar coverage from similar insurers
as may be necessary to continue its business at a cost that would not have a Material Adverse Effect.

 

4.16
REGULATORY PERMITS. The Company has in full force and effect all certificates, approvals, authorizations and permits from the
appropriate federal, state, local or foreign regulatory authorities and comparable foreign regulatory agencies, necessary to own, lease
or operate their respective properties and assets and conduct their respective businesses in the manner currently being conducted, and
the Company has not received any notice of proceedings relating to the revocation or modification of any such certificate, approval,
authorization or permit, except for such certificates, approvals, authorizations or permits which if not obtained, or such revocations
or modifications which, would not have a Material Adverse Effect.

 

4.17
INTERNAL ACCOUNTING CONTROLS. Except as otherwise set forth in the SEC Documents, the Company maintains a system of internal accounting
controls sufficient to provide reasonable assurance that (i) transactions are executed in accordance with management’s general
or specific authorizations; (ii) transactions are recorded as necessary to permit preparation of financial statements in conformity with
generally accepted accounting principles by a firm with membership to the PCAOB and to maintain asset accountability; (iii) access to
assets is permitted only in accordance with management’s general or specific authorization; and (iv) the recorded accountability
for assets is compared with the existing assets at reasonable intervals and appropriate action is taken with respect to any differences.
The Company’s management has determined that the Company’s internal accounting controls were not effective as of the date
of this Agreement as further described in the SEC Documents.

 

4.18
NO MATERIALLY ADVERSE CONTRACTS, ETC. The Company is not subject to any charter, corporate or other legal restriction, or any
judgment, decree, order, rule or regulation which in the judgment of the Company’s officers has or is expected in the future to
have a Material Adverse Effect. The Company is not a party to any contract or agreement which in the judgment of the Company’s
officers has or is expected to have a Material Adverse Effect.

 

4.19
TAX STATUS. The Company has made or filed all income and all other tax returns, reports and declarations required by any jurisdiction
to which it is subject (unless and only to the extent that the Company has set aside on its books provisions reasonably adequate for
the payment of all unpaid and unreported taxes) and has paid all taxes and other governmental assessments and charges that are material
in amount, shown or determined to be due on such returns, reports and declarations, except those being contested in good faith and has
set aside on its books provision reasonably adequate for the payment of all taxes for periods subsequent to the periods to which such
returns, reports or declarations apply. The Company has not received written notice of unpaid taxes in any material amount claimed by
the taxing authority of any jurisdiction, and the officers of the Company know of No basis for any such claim.

 

    11

     

    

 

4.20
CERTAIN TRANSACTIONS. Except as set forth in the SEC Documents and except for transactions pursuant to which the Company makes
payments in the ordinary course of business upon terms No less favorable than the Company could obtain from disinterested third parties
and other than the grant of stock options disclosed in the SEC Documents, none of the officers, directors, or employees of the Company
is presently a party to any transaction with the Company (other than for services as employees, consultants, officers and directors),
including any contract, agreement or other arrangement providing for the furnishing of services to or by, providing for rental of real
or personal property to or from, or otherwise requiring payments to or from any officer, director or such employee or, to the knowledge
of the Company, any corporation, partnership, trust or other entity in which any officer, director, or any such employee has a substantial
interest or is an officer, director, trustee or partner, such that disclosure would be required in the SEC Documents..

 

4.21
DILUTIVE EFFECT. The Company understands and acknowledges that the number of Common Shares issuable upon purchases pursuant to
this Agreement will increase in certain circumstances including, but not necessarily limited to, the circumstance wherein the trading
price of the Common Share declines during the period between the Effective Date and the end of the Open Period. The Company’s executive
officers and directors have studied and fully understand the nature of the transactions contemplated by this Agreement and recognize
that they have a potential dilutive effect on the shareholders of the Company. The board of directors of the Company has concluded,
in its good faith business judgment, and with full understanding of the implications, that such issuance is in the best interests of
the Company. The Company specifically acknowledges that, subject to such limitations as are expressly set forth in the Registered Offering
Transaction Documents, its obligation to issue shares of Common Share upon purchases pursuant to this Agreement is absolute and unconditional
regardless of the dilutive effect that such issuance may have on the ownership interests of other shareholders of the Company.

 

4.22
NO GENERAL SOLICITATION. Neither the Company, nor any of its affiliates, nor any person acting on its behalf, has engaged in any
form of general solicitation or general advertising (within the meaning of Regulation D) in connection with the offer or sale of the
Common Shares to be offered as set forth in this Agreement.

 

4.23
NO BROKERS, FINDERS OR FINANCIAL ADVISORY FEES OR COMMISSIONS. No brokers, finders or financial advisory fees or commissions
will be payable by the Company, or its agents, with respect to the transactions contemplated by this Agreement.

 

SECTION
V

COVENANTS
OF THE COMPANY

 

5.1
BEST EFFORTS. The Company shall use all commercially reasonable efforts to timely satisfy each of the conditions set forth in
Section 7 of this Agreement.

 

5.2
REPORTING STATUS. Until one of the following occurs, the Company shall concurrently file all reports with the SEC as and when
required to be filed pursuant to applicable U.S., and the Company shall not terminate its status, or take an action or fail to take any
action, which would terminate its status as a reporting company under the 1934 Act: (i) this Agreement terminates pursuant to Section
8 and the Investor has the right to sell all of the Securities without volume restrictions pursuant to Rule 144, if available, promulgated
under the 1933 Act, or such other available exemption, or (ii) the date on which the Investor has sold all the Securities and this Agreement
has been terminated pursuant to Section 8.

 

5.3
USE OF PROCEEDS. The Company will use the proceeds from the sale of the Securities (excluding amounts paid or to be paid by the
Company for fees as set forth in the Registered Offering Transaction Documents, if any) for general corporate and working capital purposes,
for acquisitions of assets, businesses or operations or for other purposes that the board of directors of the Company, in its good faith
deem to be in the best interest of the Company and its shareholders.

 

5.4 FINANCIAL
INFORMATION. During the Open Period, the Company agrees to make available to the Investor via EDGAR or other electronic means
the following documents and information on the forms set forth: (i) within five (5) Trading Days after the filing thereof, a copy of
its Annual Reports on Form 20-F, and any reports on Form 6-K and any Registration Statements or amendments filed pursuant to the
1933 Act; (ii) copies of any notices and other information made available or given to the shareholders of the Company generally,
contemporaneously with the making available or giving thereof to the shareholders; and (iii) within two (2) calendar days of filing
or delivery thereof, copies of all documents filed with, and all correspondence sent to, the Principal Market, any securities
exchange or market, or the Financial Industry Regulatory Association, unless such information is material nonpublic
information.

 

    12

     

    

 

5.5 [Reserved].

 

5.6
LISTING. The Company shall use all commercially reasonable efforts to promptly secure and maintain the listing of all of the
Registrable Securities (as defined in the Registration Rights Agreement) on the Principal Market and each other national securities exchange
and automated quotation system, if any, upon which shares of Common Share are then listed (subject to official notice of issuance) and
shall maintain, such listing of all Registrable Securities from time to time issuable under the terms of the Registered Offering Transaction
Documents. The Company shall not take any action which would be reasonably expected to result in the delisting or suspension of the
Common Shares on the Principal Market (excluding suspensions of not more than one (1) Trading Day resulting from business announcements
by the Company). The Company shall promptly provide to the Investor copies of any notices it receives from the Principal Market regarding
the continued eligibility of the Common Shares for listing on such automated quotation system or securities exchange. The Company shall
pay all fees and expenses in connection with satisfying its obligations under this Section 5.6.

 

5.7
FILING OF FORM 6-K. On or before the date which is four (4) Trading Days after the Execution Date, the Company shall file a report
on Form 6-K with the SEC describing the terms of the transaction contemplated by the Registered Offering Transaction Documents in the
form required by the 1934 Act, if such filing is required.

 

5.8
CORPORATE EXISTENCE. The Company shall use all commercially reasonable efforts to preserve and continue the corporate existence
of the Company.

 

5.9
NOTICE OF CERTAIN EVENTS AFFECTING REGISTRATION; SUSPENSION OF RIGHT TO MAKE A PUT. The Company shall promptly notify the Investor
upon the occurrence of any of the following events in respect of a Registration Statement or related prospectus in respect of an offering
of the Securities: (i) receipt of any request for additional information by the SEC or any other federal or state governmental authority
during the period of effectiveness of the Registration Statement for amendments or supplements to the Registration Statement or related
prospectus; (ii) the issuance by the SEC or any other federal or state governmental authority of any stop order suspending the effectiveness
of any Registration Statement or the initiation of any proceedings for that purpose; (iii) receipt of any notification with respect to
the suspension of the qualification or exemption from qualification of any of the Securities for sale in any jurisdiction or the initiation
or notice of any proceeding for such purpose; (iv) the happening of any event that makes any statement made in such Registration Statement
or related prospectus or any document incorporated or deemed to be incorporated therein by reference untrue in any material respect or
that requires the making of any changes in the Registration Statement, related prospectus or documents so that, in the case of a Registration
Statement, it will not contain any untrue statement of a material fact or omit to state any material fact required to be stated therein
or necessary to make the statements therein not misleading, and that in the case of the related prospectus, it will not contain any untrue
statement of a material fact or omit to state any material fact required to be stated therein or necessary to make the statements therein,
in the light of the circumstances under which they were made, not misleading; and (v) the Company’s reasonable determination that
a post-effective amendment or supplement to the Registration Statement would be appropriate, and the Company shall promptly make available
to Investor any such supplement or amendment to the related prospectus. The Company shall not deliver to Investor any Put Notice during
the continuation of any of the foregoing events in this Section 5.9.

 

5.10
TRANSFER AGENT. Upon effectiveness of the Registration Statement, and for so long as the Registration Statement is effective,
following delivery of a Put Notice, the Company shall deliver instructions to its transfer agent to issue Shares to the Investor that
are covered for resale by the Registration Statement free of restrictive legends.

 

5.11
ACKNOWLEDGEMENT OF TERMS. The Company hereby represents and warrants to the Investor that: (i) it is voluntarily entering into
this Agreement of its own freewill, (ii) it is not entering this Agreement under economic duress, (iii) the terms of this Agreement are
reasonable and fair to the Company, and (iv) the Company has had independent legal counsel of its own choosing review this Agreement,
advise the Company with respect to this Agreement, and represent the Company in connection with this Agreement.

 

    13

     

    

 

SECTION
VI

CONDITIONS
OF THE COMPANY’S ELECTION TO SELL

 

There
is no obligation hereunder of the Company to issue and sell the Securities to the Investor. However, an election by the Company to issue
and sell the Securities hereunder, from time to time as permitted hereunder, is further subject to the satisfaction, at or before each
Closing Date, of each of the following conditions set forth below. These conditions are for the Company’s sole benefit and may
be waived by the Company at any time in its sole discretion.

 

6.1
The Investor shall have executed this Agreement and the Registration Rights Agreement and delivered the same to the Company.

 

6.2
The Investor shall have delivered to the Company the Purchase Price for the Securities being purchased by the Investor between the end
of the Pricing Period and the Closing Date via a Put Settlement Sheet; and the Investor shall have delivered to the Company a Put Settlement
Sheet in the form attached here to as Exhibit C on each applicable Closing Date.

 

6.3
The representations and warranties of the Investor shall be true and correct in all material respects as of the date when made and as
of the applicable Closing Date as though made at that time and the Investor shall have performed, satisfied and complied in all material
respects with the covenants, agreements and conditions required by the Registered Offering Transaction Documents to be performed, satisfied
or complied with by the Investor on or before such Closing Date.

 

6.4
No statute, rule, regulation, executive order, decree, ruling or injunction shall have been enacted, entered, promulgated or endorsed
by any court or governmental authority of competent jurisdiction which prohibits the consummation of any of the transactions contemplated
by this Agreement.

 

SECTION
VII

 

FURTHER
CONDITIONS OF THE INVESTOR’S OBLIGATION TO PURCHASE

 

The
obligation of the Investor hereunder to purchase Securities is subject to the satisfaction, on or before each Closing Date, of each of
the following conditions set forth below.

 

7.1
The Company shall have executed the Registered Offering Transaction Documents and delivered the same to the Investor.

 

7.2
The Common Shares shall be authorized for quotation on the Principal Market and trading in the Common Shares shall not have been
suspended by the Principal Market, the SEC, or the CSE, at any time beginning on the date hereof and through and including the
respective Closing Date (excluding suspensions of not more than one (1) Trading Day resulting from business announcements by the
Company, provided that such suspensions occur prior to the Company’s delivery of the Put Notice related to such
Closing).

 

7.3
The representations and warranties of the Company shall be true and correct in all material respects as of the date when made and as
of the applicable Closing Date as though made at that time and the Company shall have materially performed, satisfied and complied with
the covenants, agreements and conditions required by the Registered Offering Transaction Documents to be performed, satisfied or complied
with by the Company on or before such Closing Date. The Investor may request an update as of such Closing Date regarding the representation
contained in Section 4.3.

 

    14

     

    

 

7.4 The Company shall have executed and delivered to the Investor the certificate or certificates representing, or have executed electronic
book-entry transfer of, the Securities (in such denominations as the Investor shall request) being purchased by the Investor at such
Closing.

 

7.5
The board of directors of the Company shall have adopted resolutions consistent with Section 4.2(ii) (the “Resolutions”)
and such Resolutions shall not have been materially amended or rescinded prior to such Closing Date.

 

7.6
No statute, rule, regulation, executive order, decree, ruling or injunction shall have been enacted, entered, promulgated or endorsed
by any court or governmental authority of competent jurisdiction which prohibits the consummation of any of the transactions contemplated
by this Agreement.

 

7.7
The Registration Statement shall be effective and useable on each Closing Date and No stop order suspending the effectiveness of the
Registration statement shall be in effect or to the Company’s knowledge shall be pending or threatened. Furthermore, on each Closing
Date (i) neither the Company nor the Investor shall have received notice that the SEC has issued or intends to issue a stop order with
respect to such Registration Statement or that the SEC otherwise has suspended or withdrawn the effectiveness of such Registration Statement,
either temporarily or permanently, or intends or has threatened to do so (unless the SEC ’s concerns have been addressed), and
(ii) No other suspension of the use or withdrawal of the effectiveness of such Registration Statement or related prospectus shall exist.

 

7.8 At the time of each Closing, the Registration Statement (including information or documents incorporated by reference therein) and
any amendments or supplements thereto shall not contain any untrue statement of a material fact or omit to state any material fact required
to be stated therein or necessary to make the statements therein not misleading or which would require public disclosure or an updated
supplement to the prospectus.

 

7.9 [Reserved].

 

7.10
The conditions to such Closing set forth in Section 2.4 shall have been satisfied on or before such Closing Date.

 

7.11
The Company shall have certified to the Investor the number of Common Shares outstanding when a Put Notice is given to the Investor.
The Company’s delivery of a Put Notice to the Investor constitutes the Company’s certification of the existence of the necessary
number of Common Shares reserved for issuance.

 

SECTION
VIII

TERMINATION

 

This
Agreement shall terminate upon any of the following events:

 

i.
when the Investor has purchased an aggregate of Five Million Dollars ($5,000,000) in the Common Shares of the Company pursuant to
this Agreement;

ii.
on the date which is thirty-six (36) months after the Effective Date; or

iii.
at such time that the Registration Statement is No longer in effect; or

iv.
at any time at the election of the Company upon 15 days written notice.

 

Any
and all shares, or penalties, if any, due under this Agreement shall be immediately payable and due upon termination of this Agreement.

 

    15

     

    

 

SECTION
IX

SUSPENSION

 

This
Agreement shall be suspended upon any of the following events, and shall remain suspended until such event is rectified:

 

i.
The trading of the Common Shares is suspended by the SEC, the CSE, the Principal Market or FINRA for a period of two (2) consecutive
Trading Days during the Open Period, but following the lifting of any suspension under this clause I, then this Agreement shall be
immediately reinstated and effective until its earlier termination or expiration; or,

 

ii.
During the Open Period the Common Shares ceases to be registered under the 1934 Act or listed or traded on the Principal Market or
the Registration Statement is No longer effective (except as permitted hereunder).

 

Immediately
upon the occurrence of one of the above-described events, the Company shall send written notice of such event to the Investor. Immediately
upon the occurrence of one of the above-described event items (i) or (ii) of this Section IX, the Company shall send written notice of
such event to the Investor. Upon the rectifying, curing or the lifting of an suspension/event noted in items (i) or (ii) above, the Company
shall send written notice (which may take the form of an email) to Investor, the date of which (or the cure date set forth in such notice)
shall be the date that the Agreement shall be once again effective.

 

SECTION
X

MISCELLANEOUS

 

10.1
LAW GOVERNING THIS AGREEMENT. This Agreement shall be governed by, and construed and interpreted in accordance with, the substantive
laws of the State of New York without giving effect to any conflict of laws rule or principle that might require the application of the
laws of another jurisdiction. Any dispute, claim, suit, action or other legal proceeding arising out of the transactions contemplated
by this Agreement or the rights and obligations of each of the parties shall be brought only in a competent court in State and City of
New York or in the federal courts of the United States of America located in the Southern District of New York. The parties to this Agreement
hereby irrevocably waive (i) any right to a jury trial and (ii) any objection to jurisdiction and venue of any action instituted hereunder
and shall not assert any defense based on lack of jurisdiction or venue or based upon forum non conveniens. The parties executing
this Agreement and other agreements referred to herein or delivered in connection herewith agree to submit to the in personam jurisdiction
of such courts. In the event that any provision of this Agreement or any other agreement delivered in connection herewith is invalid
or unenforceable under any applicable statute or rule of law, then such provision shall be deemed inoperative to the extent that it may
conflict therewith and shall be deemed modified to conform with such statute or rule of law. Any such provision which may prove invalid
or unenforceable under any law shall not affect the validity or enforceability of any other provision of any agreement. Each party hereby
irrevocably waives personal service of process and consents to process being served in any suit, action or proceeding in connection with
this Agreement or any other Transaction Documents by mailing a copy thereof via registered or certified mail or overnight delivery (with
evidence of delivery) to such party at the address in effect for notices to it under this Agreement and agrees that such service shall
constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any
right to serve process in any other manner permitted by law.

 

10.2 LEGAL FEES; AND MISCELLANEOUS FEES. Except as set forth in the Registered Offering Transaction Documents (including but not
limited to Section 5 of the Registration Rights Agreement), each party shall pay the fees and expenses of its advisers, counsel, accountants
and other experts, if any, and all other expenses incurred by such party incident to the negotiation, preparation, execution, delivery
and performance of this Agreement. Any attorneys ’fees and expenses incurred by either the Company or the Investor in connection
with the preparation, negotiation, execution and delivery of any amendments to this Agreement or relating to the enforcement of the
rights of any party, after the occurrence of any breach of the terms of this Agreement by another party or any default by another party
in respect of the transactions contemplated hereunder, to the extent that it is determined in a final judgment by a court of competent
jurisdiction that such loss, claim, damage, expense or liability resulted directly from any such act or failure to act undertaken or
omitted to be taken by such party through its gross negligence or willful misconduct, shall be paid on demand by the party which breached
the Agreement and/or defaulted, as the case may be. The Company shall pay all stamp and other taxes and duties levied in connection
with the issuance of any Securities.

 

    16

     

    

 

10.3
COUNTERPARTS. This Agreement may be executed in any number of counterparts and by the different signatories hereto on separate
counterparts, each of which, when so executed, shall be deemed an original, but all such counterparts shall constitute but one and the
same instrument. This Agreement may be executed by facsimile transmission, PDF, electronic signature or other similar electronic means
with the same force and effect as if such signature page were an original thereof.

 

10.4
HEADINGS; SINGULAR/PLURAL. The headings of this Agreement are for convenience of reference and shall not form part of, or affect
the interpretation of, this Agreement. Whenever required by the context of this Agreement, the singular shall include the plural and
masculine shall include the feminine.

 

10.5
SEVERABILITY. If any provision of this Agreement shall be invalid or unenforceable in any jurisdiction, such invalidity or unenforceability
shall not affect the validity or enforceability of the remainder of this Agreement in that jurisdiction or the validity or enforceability
of any provision of this Agreement in any other jurisiction.

 

10.6
ENTIRE AGREEMENT; AMENDMENTS. This Agreement is the final Agreement between the Company and the Investor with respect to the terms
and conditions set forth herein, and, the terms of this Agreement may not be contradicted by evidence of prior, contemporaneous, or subsequent
oral agreements of the Parties.

 

10.7
NOTICES. Any notices or other communications required or permitted to be given under the terms of this Agreement must be in writing
and will be deemed to have been delivered (i) upon receipt, when delivered personally; (ii) upon receipt, when sent by electronic mail
(provided confirmation of transmission is mechanically or electronically generated and kept on file by the sending party); or (iii) one
(1) day after deposit with a nationally recognized overnight delivery service, in each case properly addressed to the party to receive
the same. The addresses and email addresses for such communications shall be:

 

	 	If
to the Company:
    	 	 
	 	 	 	 
	 	 	 	 
	 	 	 	 
	 	 	 	 
	 	 	 	 
	 	 	 	 
	 	If to the Investor	Strattner Alternative Credit Fund LP	 
	 	 	30 Wall Street, 8th Floor	 
	 	 	New York. NY 10005	 
	 	 	Email: compliance@strattners.com	 
	 	With a copy (which shall	 	 
	 	not constitute notice) to:	Kirton McConkie, P.C.	 
	 	 	50 East South Temple Street, Suite 400	 
	 	 	Salt Lake City, UT 84111	 
	 	 	ATTN: C. Parkinson Lloyd	 
	 	 	Email: plloyd@kmclaw.com	 

 

Each
party shall provide five (5) business days prior written notice to the other party of any change in address or email address.

 

10.8 No
ASSIGNMENT. This Agreement may not be assigned.

 

10.9
No THIRD PARTY BENEFICIARIES. This Agreement is intended for the benefit of the parties hereto and is not for the benefit of,
nor may any provision hereof be enforced by, any other person.

 

10.10
SURVIVAL. The representations and warranties of the Company and the Investor contained in Sections 3 and 4, the agreements
and covenants set forth in Section 5 and this Section 11, shall survive each of the Closings and the termination of this
Agreement.

 

    17

     

    

 

10.11
PUBLICITY. The Company and the Investor shall consult with each other in issuing any press releases or otherwise making public
statements with respect to the transactions contemplated hereby and No party shall issue any such press release or otherwise make any
such public statement without the prior consent of the other party, which consent shall not be unreasonably withheld or delayed, except
that No prior consent shall be required if such disclosure is required by law, as determined solely by the Company in consultation with
its counsel. The Investor acknowledges that this Agreement and all or part of the Registered Offering Transaction Documents may be deemed
to be “material contracts” as that term is defined by Item 601(b)(10) of Regulation S-K, and that the Company may therefore
be required to file such documents as exhibits to reports or registration statements filed under the 1933 Act or the 1934 Act. The Investor
further agrees that the status of such documents and materials as material contracts shall be determined solely by the Company, in consultation
with its counsel.

 

10.12
EXCLUSIVITY. The Company shall not pursue an equity line transaction similar to the transactions contemplated in this Agreement
with any other person or entity until the earlier of (i) the Effective Date and (ii) termination of this Agreement in accordance with
Section 8.

 

10.13
FURTHER ASSURANCES. Each party shall do and perform, or cause to be done and performed, all such further acts and things, and
shall execute and deliver all such other agreements, certificates, instruments and documents, as the other party may reasonably request
in order to carry out the intent and accomplish the purposes of this Agreement and the consummation of the transactions contemplated
hereby.

 

10.14
No STRICT CONSTRUCTION. The language used in this Agreement will be deemed to be the language chosen by the parties to express
their mutual intent, and No rules of strict construction will be applied against any party, as the parties mutually agree that each has
had a full and fair opportunity to review this Agreement and seek the advice of counsel on it.

 

10.15
REMEDIES. The Investor shall have all rights and remedies set forth in this Agreement and the Registration Rights Agreement and
all rights and remedies which such holders have been granted at any time under any other agreement or contract and all of the rights
which the Investor has by law. Any person having any rights under any provision of this Agreement shall be entitled to enforce such rights
specifically (without posting a bond or other security), to recover damages by reason of any default or breach of any provision of this
Agreement, including the recovery of reasonable attorney’s fees and costs, and to exercise all other rights granted by law.

 

10.16
PAYMENT SET ASIDE. To the extent that the Company makes a payment or payments to the Investor hereunder or under the Registration
Rights Agreement or the Investor enforces or exercises its rights hereunder or thereunder, and such payment or payments or the proceeds
of such enforcement or exercise or any part thereof are subsequently invalidated, declared to be fraudulent or preferential, set aside,
recovered from, disgorged by or are required to be refunded, repaid or otherwise restored to the Company, a trustee, receiver or any
other person under any law (including, without limitation, any bankruptcy law, state or federal law, common law or equitable cause of
action), then to the extent of any such restoration the obligation or part thereof originally intended to be satisfied shall be revived
and continued in full force and effect as if such payment had not been made or such enforcement or setoff had not occurred.

 

10.17
COMMITMENT FEE SHARES. Upon entry into this Investment Agreement, the Company commits to issue to the Investor 250,000 of its
Common Shares as a commitment fee for this financing facility (the “Commitment Fee Shares”), which shall be issued
and delivered to Investor within ten (10) Trading Days of the Execution Date. The Company agrees that the issuance of the Commitment
Fee Shares is a material obligation and that the Commitment Fee Shares are considered fully-earned as of the Execution Date of this Agreement,
regardless of whether or not the Company files the S-1 or is successful in having it deemed effective by the SEC.

 

    18

     

    

 

SECTION
XI

NON-DISCLOSURE
OF NON-PUBLIC INFORMATION

 

11.1
NO DISCLOSURE OF NON-PUBLIC INFORMATION. The Company shall not disclose non-public information to the Investor, its advisors,
or its representatives.

 

11.2
NO REQUIREMENT TO DISCLOSE NON-PUBLIC INFORMATION. Nothing in the Registered Offering Transaction Documents shall require or be
deemed to require the Company to disclose non-public information to the Investor or its advisors or representatives, and the Company
represents that it does not disseminate non-public information to any investors who purchase stock in the Company in a public offering,
to money Managing Members or to securities analysts, provided, however, that notwithstanding anything herein to the contrary, the Company
will, as hereinabove provided, immediately notify the advisors and representatives of the Investor and, if any, underwriters, of any
event or the existence of any circumstance (without any obligation to disclose the specific event or circumstance) of which it becomes
aware, constituting non-public information (whether or not requested of the Company specifically or generally during the course of due
diligence by such persons or entities), which, if not disclosed in the prospectus included in the Registration Statement would cause
such prospectus to include a material misstatement or to omit a material fact required to be stated therein in order to make the statements,
therein, in light of the circumstances in which they were made, not misleading. Nothing contained in this Section 12 shall be
construed to mean that such persons or entities other than the Investor (without the written consent of the Investor prior to disclosure
of such information) may not obtain non-public information in the course of conducting due diligence in accordance with the terms of
this Agreement and nothing herein shall prevent any such persons or entities from notifying the Company of their opinion that based on
such due diligence by such persons or entities, that the Registration Statement contains an untrue statement of material fact or omits
a material fact required to be stated in the Registration Statement or necessary to make the statements contained therein, in light of
the circumstances in which they were made, not misleading.

 

SECTION
XII

ACKNOWLEDGEMENTS
OF THE PARTIES

 

Notwithstanding
anything in this Agreement to the contrary, the parties hereto hereby acknowledge and agree to the following: (i) the Investor makes
No representations or covenants that it will not engage in trading in the securities of the Company, other than the Investor will not
short or pre-sell, either directly or indirectly through its affiliates, principals or advisors, the Common Shares at any time during
the Open Period; (ii) the Company shall comply with its obligations under Section 5.8 in a timely manner; (iii) the Company has not and
shall not provide material non-public information to the Investor unless prior thereto the Investor shall have executed a written agreement
regarding the confidentiality and use of such information; and (iv) the Company understands and confirms that the Investor will be relying
on the acknowledgements set forth in clauses (i) through (iii) above if the Investor effects any transactions in the securities of the
Company.

 

[Signature
page follows.]

 

    19

     

    

 

Your
signature on this Signature Page evidences your agreement to be bound by the terms and conditions of the Investment Agreement as of the
date first written above. The undersigned signatory hereby certifies that he has read and understands the Investment Agreement, and the
representations made by the undersigned in this Investment Agreement are true and accurate, and agrees to be bound by its terms.

 

	 	INVESTOR
	 	Strattner Alternative Credit Fund LP
	 	 	 
	 	By:	/s/ Timo Strattner
        
	 	Name:  	TIMO STRATTNER
	 	Title:	DIRECTOR
	 	 	 
	 	COMPANY
	 	Sharing Economy International Inc.
	 	 	 
	 	By:	/s/ Chan Che Chung Anthony     
	 	Name:	Chan Che Chung Anthony
	 	Title:	Chairman

 

    20

     

    

 

LIST OF EXHIBITS

 

	EXHIBIT A	Registration Rights Agreement
	EXHIBIT B	Put Notice
	EXHIBIT C	Put Settlement Sheet
	EXHIBIT D	U.S. Accredited Investor Certificate  

 

    21

     

    

 

EXHIBIT
A

 

REGISTRATION
RIGHTS AGREEMENT

 

See
attached.

 

    22

     

    

 

EXHIBIT
B

 

FORM
OF PUT NOTICE

 

Date:
 

RE:
Put Notice Number __________________________________

Dear
Mr.  ____________________________________________,

 

This
is to inform you that as of today, ________________________, a ___________________ corporation (the “Company”), hereby elects
to exercise its right pursuant to the Investment Agreement to require Strattner Alternative Credit Fund LP, to purchase shares of its
Common Share. The Company hereby certifies that:

 

Put Amount in Shares: ______________________________________.

 

The Pricing Period runs from
________________________________ until ___________________________________.

 

The current number of Common Shares issued and outstanding is:
___________________________________________.

 

The number of shares currently available for resale on the S-1
is: ____________________________________________.

 

	Regards,	 
	 	 
	 	 
	By:	 	 
	 	 	 
	Name:	 	 
	 	 	 
	Title:	 	 

 

    23

     

    

 

EXHIBIT
C

 

PUT SETTLEMENT SHEET

 

	Date:	 	 
	 	 	 
	Dear	 	,

 

Pursuant
to the Put given by ___________________________, a corporation organized under the laws of
___________________ (the “Company”), to Strattner Alternative Credit Fund LP (the “Investor”) on
_________________, 202_, we are now submitting the purchase price for the Common Shares.

 

Purchase
Price per Common Share: _______________________________________.

 

Shares
Being Purchased _______________________________________________.

 

Total
Purchase Price: _________________________________________________.

 

Please
have a certificate bearing no restrictive legend issued to the Investor immediately and sent via DWAC to the following account:

 

[INSERT]

 

If
not DWAC eligible, please send FedEx Priority Overnight to:

 

[INSERT
ADDRESS]

 

Once
the conditions of Section 2.5 have been met, we will have the funds wired to the Company.

 

	Regards,	 
	 	 
	 	 
	By:	 	 
	 	 	 
	Name:	 	 
	 	 	 
	Title:	 	 

 

    24

     

    

 

EXHIBIT
D

 

[TO
BE PROVIDED}

 

 

25

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00335-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00335-of-00352.parquet"}]]